TSS:Rfhg 150494.1

Basic information about the TSS

---

TSS ID: rfhg_150494.1 Species: human Chr: chr12		Start: 51238783 End: 51238787 Strand: +
Source datasets	PRJNA548673
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2558366,EH38E1611539)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000552173.5:31 GeneID: 9802 HGNC/MGI_ID: HGNC:2684 UniProt_ID: Nearer transcript ids and distances: ENST00000549555.5:37 AK303828:37 ENST00000439799.6:39 ENST00000412716.8:39 ENST00000425012.6:39 NM_001136268.2:39 NM_001136267.2:39 NM_001136264.2:39 NM_001136266.2:39 NM_014764.4:39 NM_001136269.2:39 AK290119:39 AY430097:39 BX647278:39 AK293330:39 ENST00000551919.5:40 ENST00000549041.1:50 D31767:52 BC002334:55 BC007900:56 ENST00000449723.7:-59 ENST00000549732.6:67 AK095963:78 LF337998:81 MA573575:81 ENST00000604900.5:99 LF210452:-110 MA446029:-110 ENST00000436900.2:116 ENST00000551534.5:118 AB385271:119 CU677910:120 HQ447212:120 KJ892852:120 ENST00000552459.2:121 AK125855:121 ENST00000549497.5:127 view more...

Gene_name: DAZAP2 Gene_symbol: DAZAP2 Gene_synonyms: KIAA0058 Gene_source: HGNC:2684

TATA-Box annotation

---

Distance to TSS:	-41
Nearest PromoterID:	NM_014764
Entrez ID:	9802
Nearest Unigene:	Hs.369761
Nearest Refseq:	NM_014764
Nearest Ensembl:	ENSG00000183283
Gene Name:	DAZAP2
Gene Alias:	PRTB
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DAZAP2 p2@DAZAP2 p3@DAZAP2 p4@DAZAP2 p5@DAZAP2 p6@DAZAP2
Sample		p1@DAZAP2	p2@DAZAP2	p3@DAZAP2	p4@DAZAP2	p5@DAZAP2	p6@DAZAP2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	148.83	14.42	4.87	2.92	0.58	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	142.23	14.57	7.89	3.24	0.81	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	155.09	12.73	7.14	2.70	0.19	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	138.05	12.68	4.99	2.08	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	153.88	9.45	5.40	3.82	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	152.72	13.57	5.81	3.49	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	161.02	14.16	9.80	3.92	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	151.39	14.05	8.24	4.12	0.73	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	163.28	13.46	8.33	2.35	0.64	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	94.48	9.85	7.54	2.32	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	96.21	10.11	6.47	2.02	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	102.86	9.35	10.57	3.25	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	87.85	10.96	1.13	1.13	1.45	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	88.11	10.22	1.05	0.30	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	97.70	12.29	0.00	0.88	0.88	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	86.26	13.58	0.75	0.75	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	90.64	11.14	1.09	1.31	1.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	84.36	9.70	1.27	1.27	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	78.91	14.40	1.07	1.07	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	78.08	7.82	1.50	0.45	0.90	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	95.69	9.62	0.94	0.80	1.60	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	90.28	10.01	2.93	0.52	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	96.17	10.21	1.68	0.52	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	88.82	9.71	2.43	0.49	1.46	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	88.23	10.58	2.32	1.03	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	91.16	16.78	1.58	1.27	2.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	90.66	11.54	3.85	0.55	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	88.88	9.19	2.59	1.18	1.65	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	83.02	10.01	2.10	1.13	2.10	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	86.32	10.50	2.17	0.90	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	86.04	13.19	1.88	0.84	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	93.59	11.33	3.13	0.98	1.17	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	96.86	11.18	1.90	0.63	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	135.91	17.98	3.96	1.48	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	88.26	14.02	3.18	0.37	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	78.18	10.35	1.72	0.57	1.34	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	85.43	11.45	2.25	0.61	1.23	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	100.94	13.50	2.22	0.20	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	111.82	10.26	3.24	0.00	1.62	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	103.23	12.24	3.36	0.24	2.16	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	106.57	10.59	1.65	0.71	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	121.21	17.27	3.22	0.59	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	82.46	16.24	2.11	0.21	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	96.33	12.59	2.80	0.87	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	110.22	14.05	3.01	1.41	2.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	101.43	13.49	2.79	0.93	1.16	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	81.33	14.39	2.64	1.44	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	99.25	13.71	2.09	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	87.13	11.97	2.39	0.72	1.68	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	95.44	14.56	1.82	0.81	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	110.27	13.53	4.71	1.23	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	97.40	11.34	2.22	0.89	1.56	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	461.74	27.98	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	100.07	17.74	1.77	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	74.56	11.60	1.33	0.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	343.96	41.95	8.39	1.68	5.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	196.10	19.75	3.67	1.38	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	84.27	11.02	1.94	0.65	1.62	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	70.01	10.28	2.25	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	160.31	18.55	5.03	0.63	1.89	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	81.79	11.28	2.12	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	66.17	5.61	0.56	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	228.49	39.01	4.78	0.80	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	126.05	19.71	1.36	1.70	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	81.88	12.35	2.27	0.32	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	61.41	8.52	2.13	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	64.66	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	363.28	47.38	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	70.20	12.19	1.95	0.00	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	87.27	13.88	1.49	0.50	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	88.66	15.48	1.88	0.47	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	119.89	18.22	3.64	1.32	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	70.22	13.61	0.62	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	84.39	15.29	1.53	0.92	1.22	0.31
Adipocyte - breast, donor1	11376-118A8	151.73	23.44	5.39	0.48	0.63	0.48
Adipocyte - breast, donor2	11327-117E4	125.45	21.02	5.13	1.60	1.44	0.32
Adipocyte - omental, donor1	11473-119C6	164.12	27.86	5.85	1.27	1.65	0.38
Adipocyte - omental, donor2	11474-119C7	130.06	15.70	3.74	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	119.23	14.74	4.35	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	106.54	14.04	3.19	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	60.47	7.70	4.40	0.00	3.30	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	111.10	14.90	4.06	0.00	0.45	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	90.71	12.69	2.43	1.39	1.22	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	155.09	31.68	4.50	1.56	5.28	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	137.44	19.82	3.86	0.77	2.06	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	150.54	19.51	5.02	1.39	1.95	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	154.59	26.45	3.53	1.76	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	144.22	19.55	4.50	1.53	2.09	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	153.95	21.95	4.84	1.29	3.23	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	126.37	24.53	3.20	1.07	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	120.75	13.35	4.45	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	75.69	11.64	4.16	0.83	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	148.44	14.32	3.52	0.50	2.76	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	105.05	16.04	4.58	2.62	1.64	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	77.94	9.13	3.04	1.52	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	122.21	19.23	8.40	2.21	0.66	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	57.37	7.89	6.45	1.08	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	87.46	15.57	3.59	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	140.87	19.25	6.30	1.62	0.72	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	115.47	13.39	6.69	3.35	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	137.86	23.01	5.55	0.62	1.85	1.03
Anulus Pulposus Cell, donor1	11248-116E6	164.77	23.11	4.00	2.75	1.60	1.49
Anulus Pulposus Cell, donor2	11463-119B5	108.49	14.20	2.94	2.69	0.00	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	109.18	23.36	5.84	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	124.60	26.92	7.81	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	55.65	19.26	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	126.15	27.50	8.97	1.20	0.60	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	134.05	22.76	10.12	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	54.79	11.22	1.98	1.32	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	110.46	24.37	9.10	0.97	1.30	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	126.21	20.39	7.77	2.43	0.97	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	68.89	9.50	1.19	1.19	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	110.73	25.61	6.78	0.38	1.13	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	120.46	33.38	7.26	2.18	1.45	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	66.45	18.81	3.76	1.25	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	108.23	23.39	5.27	0.66	0.82	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	139.21	27.30	10.92	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	76.30	17.04	4.83	0.60	0.90	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	111.98	26.25	6.97	0.00	2.14	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	100.32	20.41	3.97	0.94	1.13	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	85.26	16.57	5.08	0.80	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	124.86	27.31	11.71	3.90	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	110.13	21.40	5.97	0.83	0.50	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	63.64	24.01	6.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	106.20	42.48	17.70	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	113.38	22.64	6.00	1.72	1.37	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	16.78	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	126.70	26.70	9.71	1.94	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	113.84	20.87	7.21	1.14	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	59.36	8.48	4.85	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	120.28	25.65	13.11	1.14	0.57	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	98.98	16.25	3.85	2.57	0.64	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	71.49	15.74	4.13	3.36	0.52	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	117.77	25.81	6.10	1.41	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	91.32	14.47	3.86	0.64	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	47.09	14.27	2.14	1.43	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	108.22	22.23	8.77	1.75	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	88.52	19.27	4.22	1.20	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	59.40	14.26	5.94	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	104.76	27.97	6.61	1.53	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	94.23	19.10	5.09	0.76	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	66.71	10.80	3.81	1.91	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	119.53	24.17	9.49	2.16	1.73	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	93.57	14.82	5.72	1.91	1.27	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	65.54	13.63	6.09	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	105.81	19.84	4.72	0.94	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	102.22	17.46	4.07	0.85	2.54	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	62.54	23.16	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	135.20	52.81	21.13	6.34	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	114.92	20.58	6.86	1.50	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	63.78	15.64	6.62	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	112.26	29.16	9.48	0.73	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	114.48	18.85	8.97	2.53	0.46	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	48.46	17.85	10.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	77.03	17.80	5.08	0.76	1.02	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	111.89	23.33	5.99	0.83	1.24	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	74.36	17.44	6.12	1.53	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	146.27	30.59	10.04	1.43	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	112.42	24.39	5.54	1.77	1.77	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	56.45	19.84	1.53	1.53	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	114.65	23.82	3.32	2.77	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	101.68	16.68	4.24	2.91	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	74.51	17.45	3.27	0.73	1.82	1.45
Astrocyte - cerebellum, donor1	11500-119F6	159.42	22.11	8.47	2.21	0.00	1.72
Astrocyte - cerebellum, donor2	11580-120F5	106.46	11.30	3.59	2.57	0.17	1.03
Astrocyte - cerebellum, donor3	11661-122F5	96.90	16.36	2.52	1.47	0.84	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	172.55	26.84	8.02	2.09	1.74	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	126.18	24.10	7.44	3.40	1.94	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	144.24	23.42	8.50	2.68	2.54	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	180.40	17.55	3.78	1.38	3.90	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	187.17	17.41	4.26	1.13	4.76	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	157.15	15.59	2.16	1.14	2.84	0.11
Basophils, donor1	12241-129G9	872.47	177.84	49.17	0.26	6.28	0.26
Basophils, donor2	12242-129H1	887.56	170.30	47.26	0.36	7.94	0.36
Basophils, donor3	12243-129H2	724.55	155.52	43.36	1.47	12.05	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	113.19	21.13	6.47	0.22	0.43	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	79.09	11.89	3.20	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	143.47	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	53.98	11.30	1.88	1.88	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	58.23	11.44	2.50	1.66	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	47.90	8.06	2.07	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	136.94	9.36	2.88	1.62	1.80	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	145.72	25.25	6.60	0.41	2.68	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	181.43	37.26	8.38	0.93	1.63	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	247.83	80.90	21.74	1.28	4.48	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	558.46	155.13	31.03	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	617.66	123.98	24.80	1.13	7.33	1.13
CD14+ Monocytes, donor2	11305-117B9	731.45	133.45	32.11	1.30	5.75	0.74
CD14+ Monocytes, donor3	11381-118B4	580.67	88.91	24.37	2.20	7.46	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	448.62	85.76	16.70	1.70	7.64	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	449.58	76.57	15.92	0.38	6.82	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	465.83	92.05	18.08	0.99	5.59	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	775.79	193.98	54.64	3.18	10.84	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	576.63	111.95	37.11	1.81	4.22	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	661.40	145.69	41.93	1.42	4.03	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	659.72	177.11	46.03	2.01	8.04	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	499.03	120.89	40.02	0.55	3.86	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	733.13	172.31	63.72	1.74	4.71	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	673.36	164.47	40.73	1.96	6.07	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	481.80	107.19	25.46	0.71	4.27	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	801.10	185.64	50.71	1.74	4.13	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	651.34	172.55	47.06	1.17	7.02	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	576.08	124.09	52.27	1.58	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	655.63	159.75	58.80	1.11	5.55	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	745.38	192.48	52.21	1.78	8.33	1.93
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	618.20	138.69	51.88	0.80	3.39	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	713.71	189.04	57.88	0.83	6.45	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	804.41	217.80	59.94	3.20	10.75	1.83
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	549.90	136.40	47.73	0.90	3.39	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	627.19	155.82	41.46	0.44	5.24	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	620.56	138.53	34.70	1.34	5.11	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	633.12	127.88	29.66	1.22	7.15	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	829.02	172.12	44.19	2.95	2.10	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	736.13	179.30	49.05	1.84	6.06	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	492.47	128.58	37.34	0.35	3.87	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	691.43	173.30	53.09	2.63	6.14	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	548.93	134.97	26.68	0.70	5.06	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	558.63	105.18	26.39	1.49	6.69	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	876.85	204.34	56.69	1.94	5.39	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	615.46	170.35	45.45	2.05	4.09	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	564.89	136.30	48.91	0.70	3.25	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	603.88	164.48	55.68	1.62	2.78	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	685.50	132.96	30.30	1.31	4.36	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	729.02	163.08	48.51	2.08	7.62	2.77
CD14+CD16+ Monocytes, donor3	11912-125G4	663.49	124.99	29.89	1.73	8.23	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	877.96	188.89	49.68	1.71	9.34	3.74
CD14+CD16- Monocytes, donor2	11799-124C8	831.31	180.23	40.34	2.10	5.94	2.79
CD14+CD16- Monocytes, donor3	11910-125G2	1171.48	212.04	49.50	1.78	10.48	2.45
CD14-CD16+ Monocytes, donor1	11790-124B8	462.12	108.19	29.09	0.51	7.66	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	652.33	141.62	40.84	1.76	5.27	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	661.54	110.12	27.58	1.68	6.11	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	375.98	54.87	10.16	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	414.92	60.34	13.56	0.68	4.07	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	443.24	68.35	9.32	1.04	6.21	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	437.62	62.37	19.19	1.07	10.66	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	535.00	68.62	11.79	0.54	5.90	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	442.22	68.09	6.32	0.00	2.11	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	415.71	63.53	11.77	0.78	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	450.85	54.05	9.23	0.00	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	761.90	110.96	35.34	0.00	4.11	0.00
CD19+ B Cells, donor2	11624-122B4	800.15	124.77	44.98	0.00	10.88	0.73
CD19+ B Cells, donor3	11705-123B4	793.08	125.70	31.80	1.01	5.05	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	532.95	29.09	6.87	1.62	5.25	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	354.75	25.17	3.20	2.40	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	220.89	68.28	25.10	0.00	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	464.62	115.73	61.80	1.12	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	282.57	53.73	14.65	1.13	2.25	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	298.77	59.53	15.78	0.23	5.86	0.45
CD4+ T Cells, donor1	11225-116C1	944.42	64.98	23.21	2.50	7.14	1.79
CD4+ T Cells, donor2	11306-117C1	708.50	55.11	20.21	4.90	4.29	1.84
CD4+ T Cells, donor3	11382-118B5	746.01	71.37	27.14	1.22	4.88	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	569.69	82.19	16.34	1.53	6.38	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	515.68	80.63	10.56	0.67	8.53	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	464.82	68.99	12.65	0.29	7.76	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	883.71	88.18	33.19	2.37	6.16	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	962.88	97.62	28.80	2.11	7.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	873.50	46.15	29.67	6.59	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	487.59	89.17	18.21	1.30	4.05	1.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	359.43	62.87	8.64	0.68	4.41	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	347.72	53.52	9.99	0.32	5.16	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	776.45	106.70	38.11	0.45	4.03	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	886.75	110.76	34.94	2.45	6.64	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	890.08	89.32	26.84	0.44	5.28	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	621.08	79.27	14.34	0.42	1.69	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	340.33	50.07	8.31	0.21	3.74	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	320.09	46.78	7.68	1.00	2.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	800.85	82.12	24.20	1.63	4.35	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1015.09	91.65	25.19	1.61	2.68	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	966.55	84.28	21.52	1.79	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	556.66	85.67	13.54	1.30	4.64	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	541.33	74.95	16.46	1.52	4.33	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	502.47	68.93	16.60	0.63	6.72	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	658.80	74.83	20.22	0.51	2.53	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	733.49	86.22	21.66	2.17	3.90	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1003.68	98.49	21.35	0.00	4.36	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	592.85	71.76	13.86	0.49	4.45	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	569.61	67.39	16.62	0.92	1.85	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	536.00	67.00	9.77	0.00	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	796.45	81.14	28.25	1.38	0.83	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	964.88	82.45	28.47	1.23	0.74	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	559.02	83.16	18.48	1.54	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	627.42	73.41	18.62	0.72	6.09	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	587.24	77.56	22.16	1.38	6.92	0.00
CD8+ T Cells, donor1	11226-116C2	763.16	90.36	35.69	1.64	4.58	0.98
CD8+ T Cells, donor2	11307-117C2	623.59	73.21	24.03	1.88	4.51	0.38
CD8+ T Cells, donor3	11383-118B6	697.88	60.09	23.73	2.02	7.83	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	96.12	15.37	4.13	1.15	1.38	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	85.79	16.30	4.55	0.72	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	87.82	15.59	3.28	0.00	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	145.00	20.41	6.90	0.60	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	116.39	21.60	4.32	0.72	1.44	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	95.50	19.78	6.14	0.45	1.59	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	99.30	15.21	4.13	0.22	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	99.75	17.37	5.00	0.53	0.53	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	91.70	14.77	3.75	0.70	0.94	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	111.09	15.40	5.43	0.00	1.81	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	85.70	19.17	4.65	0.58	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	95.65	18.38	4.00	0.00	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	123.01	17.07	6.13	1.31	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	116.59	18.67	6.38	0.46	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	125.31	16.41	7.46	1.49	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	120.65	19.09	6.48	0.36	1.80	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	132.64	19.85	4.89	0.58	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	100.88	21.68	4.01	0.47	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	134.05	17.11	5.07	0.32	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	116.57	21.84	4.00	0.92	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	124.71	19.88	3.21	0.64	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	114.36	14.53	4.21	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	89.46	12.22	3.55	0.39	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	87.74	12.10	3.03	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	109.20	12.04	6.42	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	77.64	12.59	6.29	0.00	1.40	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	134.23	18.03	6.01	0.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	219.33	78.59	1.83	0.00	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	127.97	16.80	2.47	0.49	0.99	0.99
Cardiac Myocyte, donor3	11686-122I3	119.75	20.31	4.21	1.47	1.47	0.53
Chondrocyte - de diff, donor1	11261-116G1	147.33	19.07	6.93	1.04	0.00	1.39
Chondrocyte - de diff, donor2	11338-117F6	104.48	17.41	4.98	1.07	1.78	0.36
Chondrocyte - de diff, donor3	11410-118E6	142.57	20.48	5.69	1.71	2.84	1.93
Chondrocyte - re diff, donor2	11339-117F7	188.00	42.08	10.74	2.69	1.79	0.90
Chondrocyte - re diff, donor3	11411-118E7	110.81	28.71	3.64	0.40	2.83	2.43
Ciliary Epithelial Cells, donor1	11242-116D9	150.45	24.33	4.82	1.95	1.26	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	87.64	19.45	2.78	2.14	1.71	1.92
Ciliary Epithelial Cells, donor3	11399-118D4	111.86	16.55	3.72	2.12	1.77	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	426.68	60.06	13.30	4.77	4.03	1.83
Corneal Epithelial Cells, donor1	11526-119I5	125.60	20.64	4.39	1.54	1.10	0.00
Corneal Epithelial Cells, donor2	11606-120I4	164.95	26.16	4.55	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	118.36	16.36	2.81	1.79	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	194.48	36.16	5.94	0.50	2.64	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	193.03	34.70	6.31	0.63	1.89	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	189.79	37.96	10.35	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	183.04	30.67	5.83	1.08	4.54	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	819.94	83.02	16.40	1.02	6.15	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	702.49	77.69	19.59	1.96	9.14	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	774.80	58.56	15.97	1.45	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	91.39	25.52	7.84	1.17	1.83	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	61.02	9.39	7.04	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	95.87	25.45	4.81	0.85	1.41	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	55.83	14.94	5.90	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	80.57	22.69	5.53	1.45	0.58	1.45
Endothelial Cells - Artery, donor2	11341-117F9	116.70	35.06	12.47	0.71	2.12	0.00
Endothelial Cells - Artery, donor3	11413-118E9	84.32	27.70	5.79	1.05	1.75	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	74.48	45.00	10.42	0.66	1.33	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	93.11	47.47	10.95	0.91	3.04	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	131.65	64.27	15.50	2.26	3.38	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	143.81	45.16	13.67	1.19	0.30	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	53.63	21.87	10.93	1.04	1.04	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	91.59	32.33	7.80	0.85	3.26	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	193.66	56.02	19.21	2.40	0.00	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	96.44	28.83	6.81	1.05	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	197.05	79.77	18.02	2.61	3.23	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	91.68	34.11	8.47	0.65	1.30	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	120.30	38.10	8.18	2.81	1.59	1.10
Endothelial Cells - Vein, donor1	11267-116G7	77.35	5.69	3.41	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	76.14	25.15	4.19	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	86.82	28.42	7.69	0.79	1.88	0.31
Eosinophils, donor1	12244-129H3	1006.30	167.72	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	2838.45	712.91	156.77	3.30	28.05	0.00
Eosinophils, donor3	12246-129H5	2286.33	492.22	96.30	7.13	32.10	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	111.66	14.66	3.91	1.22	0.49	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	87.37	16.64	8.32	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	91.13	16.83	3.69	2.87	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	50.36	11.82	3.50	1.09	0.66	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	104.22	20.04	4.12	1.30	0.87	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	107.45	23.65	5.70	1.70	2.30	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	82.70	13.37	5.32	0.82	1.23	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	98.30	18.88	4.01	2.64	1.16	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	81.95	9.49	1.84	0.26	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	127.90	18.94	3.32	1.66	2.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	91.18	11.79	1.81	0.91	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	91.71	10.61	3.03	0.76	2.27	1.52
Fibroblast - Cardiac, donor3	11417-118F4	62.61	13.88	2.68	0.47	2.37	0.32
Fibroblast - Cardiac, donor4	11452-119A3	154.28	21.22	5.76	2.12	2.12	1.82
Fibroblast - Cardiac, donor5	11456-119A7	88.45	16.75	4.19	2.03	0.76	0.51
Fibroblast - Cardiac, donor6	11460-119B2	106.12	23.19	5.61	0.76	0.00	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	182.50	27.74	7.10	2.28	0.00	2.01
Fibroblast - Choroid Plexus, donor2	11572-120E6	116.92	17.26	4.31	1.29	2.16	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	102.54	14.65	7.32	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	85.34	11.99	1.85	1.38	0.92	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	189.96	27.65	5.26	2.04	2.04	2.20
Fibroblast - Dermal, donor1	11269-116G9	62.45	11.03	1.17	0.94	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	56.13	11.79	3.30	2.36	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	68.18	11.12	2.42	1.33	1.09	0.24
Fibroblast - Dermal, donor4	11450-119A1	60.93	8.25	1.92	1.24	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	72.22	6.45	2.27	1.05	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	86.90	11.37	2.76	0.65	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	108.70	13.33	4.58	1.67	1.46	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	110.04	11.00	2.88	0.26	2.36	1.05
Fibroblast - Gingival, donor2	11318-117D4	98.71	14.89	2.64	1.45	1.71	0.13
Fibroblast - Gingival, donor3	11394-118C8	138.17	16.15	2.13	1.74	2.22	1.16
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	151.68	27.01	3.12	1.04	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	82.82	12.33	4.05	0.70	0.70	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	141.71	17.15	4.05	2.49	0.94	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	116.97	16.63	3.92	1.62	0.41	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	170.44	25.76	4.23	3.18	2.12	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	118.75	15.65	3.07	2.49	0.88	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	151.49	17.32	2.59	2.32	0.55	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	121.65	15.03	3.84	1.76	0.99	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	150.41	23.92	4.70	1.47	1.47	1.32
Fibroblast - Lung, donor1	11270-116H1	73.40	9.52	4.08	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	135.79	10.45	2.98	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	118.81	17.09	2.32	1.69	2.53	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	353.20	38.32	18.33	4.17	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	163.64	13.99	1.40	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	66.61	9.24	3.36	1.40	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	305.29	50.75	6.90	4.06	3.25	1.22
Fibroblast - Mammary, donor2	11620-122A9	159.77	3.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	113.17	17.87	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	87.68	12.41	3.30	1.36	0.58	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	105.57	14.86	2.12	1.52	1.67	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	158.50	22.95	4.28	3.06	1.53	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	125.17	11.45	2.67	1.53	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	102.60	12.69	4.59	1.62	2.16	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	92.43	16.58	2.09	1.97	1.16	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	117.50	22.55	4.20	0.77	1.33	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	273.70	42.47	7.52	4.27	1.83	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	100.90	12.03	2.00	3.34	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	81.05	10.67	1.19	0.00	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	114.31	12.11	4.17	0.60	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	142.81	19.72	3.55	1.07	0.89	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	145.05	14.98	3.35	0.59	0.79	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	97.78	6.92	2.41	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	179.74	23.86	7.45	1.73	0.00	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	131.09	10.88	3.04	0.76	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	147.01	18.70	4.10	0.98	1.48	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	87.02	9.62	2.01	0.20	0.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	163.65	22.40	6.83	1.81	0.40	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	158.67	15.41	4.53	0.30	0.00	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	154.84	23.94	2.49	0.58	1.16	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	216.25	30.94	7.86	2.56	0.00	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	113.64	9.85	1.97	0.00	0.00	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	165.32	20.45	5.75	1.92	0.00	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	140.17	19.74	5.23	1.18	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	175.17	23.37	4.23	1.57	2.98	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	842.07	66.48	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	151.65	26.15	4.36	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	87.03	16.82	6.93	1.39	0.87	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	113.73	20.04	7.81	2.08	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	96.07	19.67	5.62	2.56	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.97	5.36	3.06	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	28.71	4.47	3.19	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	35.66	6.28	1.71	1.43	0.29	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	52.95	6.34	1.38	0.83	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.00	6.85	2.51	0.68	6.85	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	24.77	3.57	0.20	0.59	0.20	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	46.79	6.08	0.53	0.53	1.32	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	47.29	8.15	2.94	1.63	0.98	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.19	3.10	1.77	1.33	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	58.65	7.35	1.84	0.71	0.14	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.85	6.03	2.34	0.86	0.37	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	33.85	4.30	0.81	0.81	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	59.72	8.92	1.24	0.74	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	57.86	8.17	0.69	1.25	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	40.86	3.86	1.22	0.41	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	70.28	8.67	2.28	1.83	1.83	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.66	7.47	1.49	0.50	0.62	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	43.72	5.25	1.31	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	93.96	10.34	3.55	1.77	1.77	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	87.74	9.54	3.02	1.59	0.79	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	81.77	11.62	2.68	0.89	0.67	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	102.63	17.34	2.82	1.61	1.81	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	113.15	12.72	3.39	2.04	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	94.26	17.91	6.03	1.06	0.80	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	238.60	36.00	9.26	1.14	1.66	1.87
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	274.10	31.76	11.27	2.39	1.02	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	124.60	17.93	5.31	1.44	1.00	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	117.81	21.96	6.07	1.83	0.50	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	144.36	22.87	7.15	1.23	0.41	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	142.56	20.01	3.30	1.65	2.06	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	137.31	20.75	5.88	1.27	0.69	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	101.39	19.18	4.00	0.83	1.33	2.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	137.99	19.40	3.97	0.44	1.76	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	203.92	26.20	4.80	2.21	1.11	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	109.09	13.62	4.21	1.30	0.81	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	201.41	23.09	4.81	1.60	2.89	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	120.15	20.56	5.02	1.14	0.85	1.52
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	108.19	18.66	2.85	1.90	1.42	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	167.86	23.41	5.47	0.61	0.91	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	122.41	21.95	6.59	1.57	0.84	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	118.34	23.71	3.29	1.10	1.76	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	136.07	24.69	5.33	2.24	1.96	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	106.57	23.61	5.93	1.20	0.65	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	114.72	23.00	6.95	1.87	2.14	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	105.27	22.34	5.51	1.38	1.99	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	109.33	20.86	6.61	1.42	1.17	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	138.79	28.73	5.96	1.63	2.98	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	106.00	21.20	5.71	0.74	2.95	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	101.98	18.42	6.36	2.19	1.75	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	240.00	56.53	7.93	2.98	5.95	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	107.64	20.45	3.69	0.79	1.71	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	90.59	17.75	5.04	1.21	1.41	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	563.22	104.97	25.67	6.61	4.07	4.07
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	47.77	6.37	2.39	0.80	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	51.31	6.63	1.69	0.31	0.00	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	56.46	8.59	0.61	1.02	0.61	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.47	4.69	0.94	0.94	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	20.63	1.70	1.13	0.57	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	22.60	3.69	2.31	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	2.47	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	24.37	2.32	1.55	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	25.67	4.81	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	5.22	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.13	2.60	0.98	0.98	0.33	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	27.59	5.35	1.24	0.41	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.64	3.08	1.12	0.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	39.87	5.56	1.96	0.65	0.00	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.00	3.36	0.00	3.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	36.58	4.45	1.27	0.95	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	33.29	3.06	1.02	0.68	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	64.72	4.58	2.29	0.00	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	37.00	3.85	0.59	0.00	0.30	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	3.39	1.69	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	47.22	4.56	1.24	0.41	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	50.40	7.13	1.38	1.15	0.69	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	42.29	7.69	2.31	1.54	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	55.41	7.50	1.30	1.96	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.79	4.01	2.01	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	89.00	5.01	2.31	0.39	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	70.18	10.95	4.11	0.68	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	4.97	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	90.60	9.44	1.42	0.00	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	87.51	10.26	1.81	1.81	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	79.86	8.65	3.05	1.53	0.00	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	93.73	9.97	1.60	0.80	0.00	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	101.14	8.39	3.45	0.99	0.49	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	83.81	5.90	1.18	2.36	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	102.69	11.09	1.17	0.58	0.00	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	132.98	9.22	2.63	3.07	0.44	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	91.55	11.02	2.54	0.00	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	71.63	8.95	4.78	0.60	0.00	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	81.52	8.25	4.37	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	77.61	14.84	5.71	0.00	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	83.16	15.80	1.66	1.66	0.42	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	70.84	5.62	0.00	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	112.91	22.84	4.44	2.22	0.95	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	74.78	13.79	5.43	1.67	1.67	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	197.16	21.70	7.43	2.44	2.44	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	216.23	22.62	7.60	2.53	0.84	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	206.57	24.80	7.28	3.19	1.14	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	193.48	26.56	7.00	2.84	1.64	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	208.03	22.78	6.66	3.44	1.07	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	203.44	22.17	5.38	3.23	1.51	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	191.04	26.03	7.85	2.37	1.99	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	184.76	22.30	7.03	2.40	1.72	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	159.87	13.14	5.45	1.60	1.60	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	156.13	48.69	17.35	1.68	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	99.98	29.00	6.92	0.87	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	166.56	44.94	2.64	0.00	2.64	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	146.38	23.28	4.94	3.53	1.76	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	111.16	23.97	2.18	3.63	1.45	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	122.21	21.16	5.59	1.92	1.22	0.52
Hepatocyte, donor1	11523-119I2	271.18	36.32	12.11	1.21	4.84	2.42
Hepatocyte, donor2	11603-120I1	386.76	18.31	14.01	2.15	2.15	0.00
Hepatocyte, donor3	11684-122I1	171.79	25.16	6.75	1.23	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	272.17	26.11	7.18	2.61	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	426.47	65.37	16.95	2.80	2.45	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	110.31	15.78	4.12	2.20	1.37	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	89.15	9.55	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	146.86	13.35	6.68	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	92.75	6.92	4.15	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	82.59	7.51	0.00	5.01	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	130.55	11.87	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	15.38	5.13	0.00	0.00	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	141.69	9.14	4.57	0.00	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	123.45	9.75	3.25	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	88.37	8.34	8.34	1.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	87.13	14.52	7.26	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	93.97	10.59	2.65	0.00	0.00	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	84.26	15.52	7.76	1.11	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	115.24	15.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	100.15	20.16	5.67	5.04	1.89	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	69.60	12.37	3.09	6.19	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	114.99	22.61	6.46	2.58	0.00	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	96.60	16.10	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	11.95	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	116.53	14.67	4.07	2.44	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	90.26	13.01	3.36	0.84	1.26	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	119.75	18.48	3.21	0.80	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	90.48	10.16	4.62	0.92	2.77	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	130.75	18.88	7.08	4.72	0.94	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	95.23	6.35	1.81	2.72	0.91	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	137.74	21.52	6.46	4.30	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	114.34	8.89	1.27	3.81	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	16.43	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	102.67	15.94	7.01	1.91	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	100.25	10.94	3.65	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	114.96	15.71	4.28	3.57	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	3.32	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	125.01	16.36	4.01	1.54	0.31	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	80.78	15.80	3.51	5.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	110.01	3.14	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	102.92	13.21	0.70	0.70	0.70	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	106.23	13.28	2.21	0.00	6.64	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	119.95	12.97	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	89.81	10.46	2.62	2.62	0.00	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	103.49	11.25	4.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	6.97	0.00	3.48	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	89.61	12.80	5.33	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	72.04	11.08	1.39	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	71.24	17.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	84.68	11.05	1.84	2.76	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	6.05	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	90.93	11.63	5.29	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	99.06	20.24	5.55	1.88	0.65	0.57
Keratinocyte - epidermal, donor2	11349-117G8	49.19	5.86	2.34	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	100.24	14.67	3.03	1.23	1.23	0.38
Keratinocyte - oral, donor1	11251-116E9	222.38	26.11	5.22	2.84	2.84	0.91
Keratocytes, donor1	11527-119I6	150.94	21.32	5.85	0.34	0.00	1.03
Keratocytes, donor2	11607-120I5	120.70	9.37	3.52	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	94.25	11.26	1.38	0.59	1.38	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	158.25	17.58	2.20	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	90.61	18.34	1.08	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	222.36	29.06	7.04	2.77	3.00	1.85
Lens Epithelial Cells, donor3	11690-122I7	111.91	18.26	3.33	2.22	1.92	1.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	142.77	56.92	18.02	1.07	2.96	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	110.79	48.84	12.00	1.12	1.40	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	132.07	64.85	19.83	1.10	2.68	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	120.45	44.63	10.75	2.15	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	115.35	48.54	12.29	0.95	1.58	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	116.98	53.69	15.09	2.05	2.26	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	130.09	41.86	18.06	1.64	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	111.75	50.82	16.94	0.51	0.76	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	122.03	53.20	14.78	2.11	1.13	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	118.66	43.11	15.43	1.19	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	138.24	54.68	15.12	0.39	3.10	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	90.17	43.51	15.37	0.74	1.30	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	137.28	54.35	14.29	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	140.73	58.68	12.88	2.15	2.15	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	112.49	55.63	16.62	1.24	2.47	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	130.27	49.27	20.02	1.23	2.16	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	113.79	43.64	13.40	0.94	1.25	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	122.42	62.95	17.20	1.65	1.83	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	131.97	54.30	14.15	2.30	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	112.76	50.67	12.89	0.88	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	103.06	49.04	13.44	0.50	1.74	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	145.00	53.35	20.85	1.45	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	124.68	49.82	13.46	2.15	1.89	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	122.31	64.79	18.47	1.51	1.36	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	130.64	52.88	18.66	2.07	1.04	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	130.45	61.56	17.80	1.68	1.88	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	114.73	53.53	18.80	1.20	1.65	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	113.50	41.96	11.01	2.06	2.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	116.65	54.00	13.55	1.69	2.07	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	114.41	54.39	17.18	1.06	1.38	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	115.81	47.97	16.48	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	114.78	48.30	14.55	0.99	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	120.79	55.38	18.96	2.48	2.73	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	148.45	69.23	18.14	1.85	1.48	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	118.60	56.83	16.31	1.48	2.72	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	116.59	53.48	18.56	1.51	2.75	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	128.66	60.47	17.69	1.61	2.25	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	141.21	54.47	19.48	1.83	1.52	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	145.56	64.10	22.11	1.82	3.36	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	126.94	48.36	14.22	1.78	1.07	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	119.74	55.26	11.63	0.97	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	106.75	50.57	12.60	1.24	2.02	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	100.27	39.75	19.34	1.07	0.72	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	113.68	52.92	21.23	1.31	0.98	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	95.58	44.73	11.30	0.71	0.71	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	132.29	53.96	17.33	2.10	3.96	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	95.02	40.72	10.50	1.79	1.79	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	108.01	50.42	11.34	0.30	2.09	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	237.93	33.99	22.66	0.00	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	349.81	45.26	15.34	4.60	6.14	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	354.78	46.76	12.62	2.97	7.42	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	349.50	54.58	18.62	0.85	2.12	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	375.57	43.61	17.58	2.81	9.14	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	354.91	42.96	9.34	0.93	4.67	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	329.26	47.92	17.00	1.55	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	330.67	48.77	10.71	1.19	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	335.22	54.51	21.04	1.36	3.39	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	341.72	48.86	17.45	3.20	1.45	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	364.64	45.47	17.11	1.35	4.95	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	412.96	66.39	21.54	2.44	2.30	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	349.71	50.33	12.84	2.05	2.05	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	358.50	43.40	19.41	3.18	3.18	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	418.44	59.97	18.66	2.00	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	303.08	49.41	16.30	3.06	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	382.87	53.09	18.68	1.60	1.87	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	363.15	47.24	17.57	2.65	3.21	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	324.57	46.63	12.88	3.07	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	397.93	55.45	23.65	3.26	3.26	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	376.30	49.77	13.74	2.29	2.08	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	352.57	45.40	18.50	2.24	1.68	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	370.92	41.21	17.52	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	349.53	48.48	17.13	2.61	2.03	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	344.67	49.02	21.52	2.69	0.60	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	368.47	46.47	16.04	1.11	4.98	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	381.41	53.73	15.55	1.77	2.47	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	356.24	47.57	19.91	2.21	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	313.15	46.05	14.97	0.00	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	335.40	54.88	14.58	1.92	2.69	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	305.14	53.22	14.72	2.26	1.13	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	319.16	45.95	18.87	0.82	4.92	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	336.65	52.42	14.46	2.71	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	306.65	50.99	17.24	0.72	3.59	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	384.66	56.76	15.68	1.49	2.99	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	335.18	47.94	13.01	2.60	1.86	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	318.32	39.20	18.95	2.15	0.86	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	377.63	52.23	18.84	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	329.18	40.31	13.99	3.00	1.67	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	343.89	41.02	18.10	3.02	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	291.51	34.84	15.64	2.13	3.55	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	336.50	54.31	17.53	1.03	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	302.73	37.04	16.64	2.15	2.68	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	286.85	32.99	14.14	0.67	4.71	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	300.03	48.52	12.22	3.33	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	237.24	27.91	15.12	3.49	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	257.03	45.48	11.64	1.06	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	287.71	40.42	16.41	0.80	3.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	292.93	39.25	17.44	2.91	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	390.16	53.66	18.40	1.53	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	365.03	52.78	18.74	2.47	2.47	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	301.10	60.22	22.58	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	353.99	53.30	16.09	2.51	2.01	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	335.26	54.07	19.38	2.70	2.25	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	294.31	29.26	8.61	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	353.16	57.00	14.25	1.78	4.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	346.84	55.53	12.90	2.35	2.35	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	299.52	46.84	17.15	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	378.82	43.59	20.76	2.08	4.67	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	368.87	56.88	18.38	3.50	2.19	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	298.56	47.52	17.33	1.68	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	360.82	42.84	17.67	0.88	2.65	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	334.80	51.30	19.29	2.70	1.54	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	323.56	42.53	17.72	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	320.57	46.14	19.22	3.36	0.96	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	361.37	56.85	13.52	1.19	3.18	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	301.38	36.46	20.66	3.04	1.82	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	304.35	38.74	15.22	2.08	0.00	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	346.93	42.94	20.14	3.04	3.42	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	323.28	41.31	14.46	2.07	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	335.58	46.56	18.74	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	318.80	47.85	11.73	1.27	2.22	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	306.53	49.04	12.26	2.67	1.60	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	343.08	50.00	19.54	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	326.54	49.88	13.37	2.06	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	345.19	43.15	14.15	0.71	2.12	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	379.65	41.99	20.43	1.70	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	361.53	49.92	14.56	2.08	0.83	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	327.31	58.73	18.79	3.92	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	422.14	56.37	22.55	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	355.45	49.72	13.47	1.86	2.32	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	307.76	44.16	22.08	2.01	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	399.38	48.65	21.92	1.07	0.53	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	335.40	46.88	17.78	3.23	2.02	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	330.39	43.13	22.94	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	413.44	56.90	17.78	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	323.12	46.73	13.11	3.42	3.99	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	319.80	39.11	14.57	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	384.12	58.55	22.98	3.28	0.55	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	353.69	44.99	14.25	2.67	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	332.48	56.93	16.64	1.56	2.08	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	360.73	47.74	24.53	0.00	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	297.24	49.89	8.31	0.00	0.00	8.31
Macrophage - monocyte derived, donor1	11232-116C8	277.15	79.31	18.23	0.68	3.19	2.05
Macrophage - monocyte derived, donor2	11313-117C8	171.76	28.08	7.16	0.73	3.85	0.18
Macrophage - monocyte derived, donor3	11389-118C3	188.63	46.27	11.54	1.97	2.75	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	89.74	15.93	4.78	2.12	1.59	0.53
Mallassez-derived cells, donor2	11929-125I3	155.92	28.36	10.14	1.43	1.43	0.48
Mallassez-derived cells, donor3	11930-125I4	151.91	24.60	6.39	2.08	0.83	0.69
Mammary Epithelial Cell, donor1	11273-116H4	69.95	13.45	1.69	1.79	1.00	1.69
Mammary Epithelial Cell, donor2	11350-117G9	101.92	13.90	2.61	2.61	1.74	1.45
Mammary Epithelial Cell, donor3	11422-118F9	53.88	7.48	1.25	0.75	1.25	0.25
Mast cell - stimulated, donor1	11487-119E2	2024.32	757.25	239.31	4.75	37.29	6.10
Mast cell, donor1	11563-120D6	502.75	179.41	68.99	2.27	8.00	1.51
Mast cell, donor2	11565-120D8	708.46	128.68	29.12	0.89	7.43	1.78
Mast cell, donor3	11566-120D9	810.67	139.35	26.56	3.38	10.81	1.35
Mast cell, donor4	11567-120E1	550.31	109.56	26.24	2.30	7.62	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	453.00	104.02	25.73	0.89	5.10	2.11
Mast cell, expanded and stimulated, donor8	11942-126A7	250.98	78.80	25.68	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	348.64	106.12	25.24	0.57	4.47	1.84
Mast cell, expanded, donor8	11941-126A6	340.26	149.63	60.08	1.67	3.68	1.67
Melanocyte - dark, donor1	11502-119F8	139.79	61.79	18.81	1.49	3.88	0.80
Melanocyte - dark, donor2	11582-120F7	133.24	22.84	3.81	1.73	1.38	1.38
Melanocyte - dark, donor3	11663-122F7	192.62	27.82	5.51	1.74	1.96	0.43
Melanocyte - light, donor1	11274-116H5	79.92	11.52	1.88	0.00	1.18	0.24
Melanocyte - light, donor2	11351-117H1	95.55	17.06	6.14	0.00	1.36	0.68
Melanocyte - light, donor3	11423-118G1	63.31	12.14	1.73	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	179.51	30.51	3.33	1.98	2.19	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	106.23	22.86	2.96	0.54	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	263.57	37.77	5.62	2.14	4.02	0.00
Meningeal Cells, donor1	11493-119E8	207.30	34.12	10.05	2.11	0.12	1.49
Meningeal Cells, donor2	11573-120E7	176.06	14.08	3.96	5.28	0.00	1.76
Meningeal Cells, donor3	11654-122E7	120.95	22.74	4.73	1.63	1.55	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	116.91	19.11	3.14	1.43	3.71	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	109.09	19.93	5.84	1.31	1.01	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	56.51	10.51	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	92.88	18.31	2.62	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	89.70	15.07	2.15	0.72	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	153.32	26.05	7.84	1.48	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	127.67	26.14	4.52	2.51	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	119.11	22.20	6.15	1.10	0.88	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	94.25	19.00	2.92	2.19	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	85.93	16.16	2.46	1.43	0.41	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	122.72	16.07	4.71	1.25	0.14	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	140.51	21.19	3.72	0.74	0.74	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	224.86	32.37	5.53	1.45	1.58	2.24
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	115.73	16.02	2.97	0.89	0.30	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	70.07	11.68	4.67	2.34	0.00	7.01
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	118.47	23.69	4.48	1.92	1.28	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	126.54	18.08	4.96	1.06	2.84	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	193.58	25.02	5.00	0.63	3.13	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	97.24	20.32	2.90	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	135.50	24.13	7.69	2.39	1.06	0.80
Mesothelial Cells, donor2	12156-128G5	70.07	18.02	5.00	2.50	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	135.13	21.25	4.34	2.75	1.59	1.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	87.77	13.50	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	263.76	52.95	12.56	0.74	3.45	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	158.42	31.51	5.59	1.18	2.36	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	242.07	41.22	8.37	1.24	2.79	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	162.83	30.70	6.43	0.83	1.87	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	41.69	11.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	264.03	45.55	14.01	1.00	4.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	157.33	31.19	4.65	0.93	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	221.91	39.42	9.96	0.81	3.86	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	121.96	28.11	2.38	1.19	2.38	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	202.65	36.28	9.73	0.88	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	166.03	28.88	8.74	0.38	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	47.37	3.95	0.00	0.00	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	220.08	45.84	8.91	0.64	2.12	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	50.65	16.57	1.84	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	173.17	38.15	5.07	2.38	1.79	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	30.18	3.35	3.35	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	231.33	45.92	13.05	0.75	2.51	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	117.88	26.86	5.70	0.95	0.24	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	39.25	8.85	2.21	0.55	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	230.48	36.61	7.14	0.69	2.99	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	129.15	28.19	6.10	0.63	2.94	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	175.50	30.57	7.75	1.22	1.43	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	261.52	42.26	13.95	1.29	3.65	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	111.15	27.79	5.11	1.11	1.56	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	207.63	42.05	8.54	1.10	3.50	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	83.14	14.70	1.52	0.51	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	56.34	11.60	4.97	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	189.44	34.25	5.98	0.27	2.17	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	108.81	18.53	5.88	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	38.16	6.54	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	211.44	35.08	6.25	0.48	3.84	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	119.67	27.22	5.20	0.40	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	46.62	8.23	2.74	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	194.22	36.04	7.01	1.00	2.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	38.73	12.23	2.04	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	225.97	32.41	10.95	0.44	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	44.15	2.21	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	62.76	10.25	1.92	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	244.20	39.91	9.67	0.25	5.21	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	45.23	6.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	260.51	38.63	8.21	0.68	3.76	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	66.52	8.75	1.75	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	54.68	9.94	0.71	0.71	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	280.55	47.41	9.54	1.68	4.21	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	85.62	17.87	3.33	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	44.29	7.58	2.91	1.17	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	182.21	34.39	9.95	0.60	3.02	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	138.16	25.46	9.18	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	145.00	29.55	5.54	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	128.05	27.89	7.40	0.57	0.57	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	124.50	28.60	4.84	0.41	1.11	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	223.65	40.43	13.73	2.07	4.15	2.33
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	126.55	24.45	8.15	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	47.00	5.08	0.64	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	133.18	30.16	6.94	1.07	2.94	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	187.08	36.52	12.27	1.80	0.90	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	126.42	26.56	5.65	0.85	1.55	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	202.26	33.76	12.74	1.27	2.87	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	153.91	33.83	10.84	1.55	1.11	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	84.56	17.06	3.79	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	222.46	49.15	9.38	1.42	2.27	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	176.98	42.03	12.54	1.72	0.49	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	59.95	13.69	3.26	0.65	2.61	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	196.41	46.16	13.82	1.47	2.94	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	194.62	38.06	12.69	1.44	2.59	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	194.94	44.92	9.48	0.41	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	193.86	33.05	9.23	0.60	3.28	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	365.39	94.17	18.83	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	221.00	35.65	14.26	0.00	3.56	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	362.09	79.51	21.36	0.33	6.57	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	212.49	27.35	8.42	2.10	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	257.98	50.61	9.88	0.79	2.57	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	210.48	33.53	4.66	0.00	4.66	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	357.88	82.99	17.65	2.25	4.88	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	220.53	37.02	8.26	0.27	3.20	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	312.05	60.96	14.36	1.24	2.71	1.36
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	247.54	55.99	14.73	1.47	2.95	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	315.86	76.95	21.99	0.73	4.03	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	241.12	62.22	7.78	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	497.56	89.25	21.38	1.60	3.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	251.15	65.69	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	288.84	75.75	12.12	2.02	5.05	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	280.81	57.76	11.38	1.26	5.06	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	649.65	118.49	38.13	1.36	2.72	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	508.00	93.46	23.52	0.64	3.18	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	642.20	144.15	43.73	8.10	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	410.84	70.99	21.15	3.02	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	279.80	79.94	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	352.34	65.25	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	218.61	23.76	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	263.53	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	104.06	19.82	5.39	1.08	0.86	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	122.81	16.72	5.23	1.05	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	56.74	16.02	2.67	1.33	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	48.42	10.02	1.25	0.42	1.25	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	133.29	25.67	5.13	1.90	2.28	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	49.47	14.36	1.60	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	25.84	6.12	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	165.39	1.84	3.68	0.00	1.84	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	41.02	12.56	1.26	0.00	0.42	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	60.43	12.55	2.79	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	62.42	12.16	2.16	1.08	0.81	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	114.16	17.66	3.36	1.89	0.63	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	456.52	66.81	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	79.91	12.41	2.98	1.49	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	92.84	18.68	1.62	1.35	2.17	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	51.68	11.11	2.95	2.04	0.91	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	58.14	10.94	1.80	0.65	0.82	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	140.88	23.51	4.01	1.09	1.09	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	80.10	18.03	4.24	0.53	1.06	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	62.43	6.60	4.80	0.60	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	216.60	25.93	8.20	2.30	2.95	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	51.88	9.92	3.42	1.79	1.30	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	123.29	20.64	6.53	1.41	0.88	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	69.62	12.66	2.11	2.81	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	65.28	7.36	5.06	0.00	0.92	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	53.99	6.43	1.93	0.00	0.96	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	214.52	32.76	9.31	2.41	4.14	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	482.93	42.98	25.28	2.53	7.59	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	89.78	14.48	2.45	0.45	0.67	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	52.92	11.85	3.81	0.85	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	80.94	15.19	3.32	1.90	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	43.78	11.16	1.29	0.43	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1083.33	54.17	18.06	9.03	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	49.98	7.00	1.33	0.67	2.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	43.73	7.21	0.45	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	41.27	4.76	1.59	0.40	0.40	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	68.72	3.71	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	82.49	11.73	2.65	0.38	1.14	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	43.99	9.12	2.28	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	55.34	4.36	1.74	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	76.44	9.05	2.71	0.45	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	53.80	6.17	2.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	68.48	7.98	3.32	0.00	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	74.41	7.94	1.49	0.99	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	37.13	9.19	1.15	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	57.46	8.47	0.60	0.60	0.91	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	93.94	11.94	1.55	1.33	0.44	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	48.11	8.13	1.36	0.00	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	337.23	25.55	10.22	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	68.28	9.15	2.44	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	41.23	4.41	0.94	0.31	0.94	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	39.34	3.33	0.91	0.00	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	44.30	7.91	0.79	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	248.27	31.74	10.20	2.27	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	298.42	20.23	5.06	0.00	10.12	5.06
Myoblast, donor1	11241-116D8	94.04	18.51	4.60	2.36	1.86	0.75
Myoblast, donor2	11322-117D8	102.03	16.11	2.88	2.11	0.77	1.15
Myoblast, donor3	11398-118D3	112.50	16.48	3.53	2.52	1.35	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	247.36	26.12	4.96	1.31	4.23	0.58
Natural Killer Cells, donor1	11230-116C6	729.43	96.56	34.44	0.31	9.84	0.31
Natural Killer Cells, donor2	11311-117C6	645.63	77.20	25.93	1.51	5.73	0.30
Natural Killer Cells, donor3	11387-118C1	637.38	76.75	26.87	2.39	6.81	1.84
Neural stem cells, donor1	11275-116H6	343.34	75.13	18.87	1.45	1.09	2.54
Neural stem cells, donor2	11352-117H2	460.23	69.32	26.96	7.70	1.93	1.93
Neurons, donor1	11494-119E9	306.09	35.27	17.07	3.41	2.28	2.28
Neurons, donor2	11574-120E8	191.54	33.68	9.03	1.54	1.98	0.88
Neurons, donor3	11655-122E8	215.41	41.11	12.33	3.29	4.11	0.00
Neutrophils, donor1	11233-116C9	2251.34	668.16	118.78	3.71	29.70	0.00
Neutrophils, donor2	11314-117C9	1748.02	487.01	98.56	2.90	17.39	0.00
Neutrophils, donor3	11390-118C4	2894.78	720.18	124.00	7.94	37.87	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	221.09	29.21	4.16	2.14	3.68	3.68
Nucleus Pulposus Cell, donor2	11409-118E5	89.87	13.68	1.30	0.65	0.33	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	81.22	10.23	2.01	0.60	0.20	1.20
Olfactory epithelial cells, donor1	11933-125I7	110.67	19.41	3.44	1.10	1.24	0.69
Olfactory epithelial cells, donor2	11934-125I8	99.73	18.53	2.32	1.01	1.01	0.72
Olfactory epithelial cells, donor3	11935-125I9	98.30	13.51	2.50	1.70	0.91	0.45
Olfactory epithelial cells, donor4	11936-126A1	121.65	14.22	2.24	1.17	1.17	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	163.09	28.89	7.22	4.81	3.01	0.60
Osteoblast - differentiated, donor1	11276-116H7	70.19	10.63	3.40	0.64	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	24.01	3.43	3.43	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	52.14	8.69	3.10	0.00	1.24	0.62
Osteoblast, donor1	11277-116H8	65.86	11.34	2.93	1.17	0.78	0.59
Osteoblast, donor2	11354-117H4	144.68	20.37	2.11	1.40	1.40	0.70
Osteoblast, donor3	11426-118G4	66.47	9.06	3.20	1.07	0.71	0.89
Pancreatic stromal cells, donor1	11249-116E7	128.37	20.13	3.87	1.77	1.60	0.76
Pericytes, donor1	11491-119E6	157.11	23.92	4.90	2.56	0.33	2.23
Pericytes, donor2	11571-120E5	106.17	9.96	3.62	0.91	0.00	1.36
Pericytes, donor3	11652-122E5	123.09	22.58	4.07	2.03	2.03	1.22
Perineurial Cells, donor1	11499-119F5	128.05	16.16	3.96	1.36	2.26	0.57
Perineurial Cells, donor2	11579-120F4	159.36	28.43	6.07	2.02	1.84	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	919.24	134.83	25.82	1.27	4.46	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	606.03	91.33	19.34	1.22	5.88	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	600.62	84.25	18.12	2.59	6.73	0.78
Placental Epithelial Cells, donor1	11278-116H9	157.85	11.72	6.70	0.48	0.48	0.72
Placental Epithelial Cells, donor2	11355-117H5	138.61	16.63	4.44	2.22	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	110.53	10.41	2.75	0.98	0.98	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	112.34	15.51	4.11	1.58	1.27	0.00
Preadipocyte - breast, donor1	11467-119B9	117.05	18.95	5.44	2.06	1.13	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	127.26	17.88	3.65	0.52	1.44	0.13
Preadipocyte - breast, donor2	11328-117E5	131.26	19.14	5.40	0.90	1.58	0.68
Preadipocyte - omental, donor1	11468-119C1	150.35	25.47	5.22	1.92	1.28	1.17
Preadipocyte - omental, donor2	11329-117E6	135.31	19.64	7.86	3.06	2.18	0.87
Preadipocyte - omental, donor3	11403-118D8	125.77	15.76	3.87	2.44	2.01	0.14
Preadipocyte - perirenal, donor1	11469-119C2	93.51	7.87	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	64.49	12.59	3.69	0.61	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	124.49	17.88	4.07	3.01	1.24	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	102.17	13.96	1.70	1.02	2.04	0.51
Preadipocyte - visceral, donor1	11280-116I2	130.69	16.11	3.82	2.79	1.12	0.75
Preadipocyte - visceral, donor2	11357-117H7	132.07	14.73	5.52	0.92	1.38	0.92
Preadipocyte - visceral, donor3	11429-118G7	75.44	9.82	2.40	1.57	0.00	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	265.35	38.32	11.01	2.56	3.02	1.36
Prostate Epithelial Cells, donor2	11331-117E8	86.39	20.45	6.36	2.98	1.22	0.81
Prostate Epithelial Cells, donor3	11404-118D9	102.76	25.90	5.70	2.08	1.47	0.55
Prostate Stromal Cells, donor1	11254-116F3	151.26	18.34	3.30	3.64	2.73	0.57
Prostate Stromal Cells, donor2	11332-117E9	139.67	25.46	3.23	4.12	1.61	0.72
Prostate Stromal Cells, donor3	11405-118E1	136.29	20.75	4.38	3.13	2.82	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	208.04	44.53	10.95	1.82	1.46	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	154.57	35.97	9.36	2.98	1.18	0.76
Renal Epithelial Cells, donor1	11517-119H5	120.21	23.84	4.57	1.52	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	142.26	27.03	6.40	3.56	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	170.76	43.30	6.67	2.65	0.53	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	117.11	33.36	10.21	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	117.92	30.32	12.94	2.29	0.27	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	160.29	37.96	8.88	2.44	1.78	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	80.52	36.60	5.99	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	176.51	33.01	6.38	3.08	0.88	2.64
Renal Mesangial Cells, donor2	11598-120H5	182.45	35.74	5.64	3.76	3.13	1.25
Renal Mesangial Cells, donor3	11679-122H5	98.76	20.53	4.44	2.77	1.94	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	191.92	39.73	8.32	1.88	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	124.82	35.42	6.75	2.53	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	119.76	23.33	4.44	3.28	1.35	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	147.53	21.00	5.19	0.78	1.56	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	171.40	31.55	7.11	1.71	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	95.71	20.58	4.12	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	120.44	23.33	4.77	1.76	1.00	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	293.20	37.82	9.35	1.34	3.34	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	96.49	9.83	4.47	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	348.38	42.38	9.91	0.00	1.65	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	216.36	29.58	7.54	2.32	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	169.16	18.07	4.29	0.91	0.39	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	142.11	15.89	2.58	1.49	1.09	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	155.49	16.73	3.12	1.12	0.67	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	243.74	21.71	4.96	1.86	0.12	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	163.98	17.95	1.86	1.17	1.05	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	180.51	21.26	3.93	1.85	0.69	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	158.95	11.23	3.01	0.41	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	126.92	13.01	3.03	1.06	1.36	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	113.43	12.72	2.33	0.54	1.25	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	188.50	13.77	3.16	0.57	0.14	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	147.34	16.31	2.47	0.54	1.40	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	129.89	14.60	0.89	1.33	0.89	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	203.41	13.96	4.01	0.57	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	136.76	17.70	2.52	0.75	1.49	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	182.27	24.80	4.51	0.94	0.75	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	156.59	14.20	4.11	1.86	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	136.96	14.50	3.41	0.58	1.46	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	179.88	24.25	3.44	1.53	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	179.52	15.27	3.42	0.64	0.21	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	134.27	14.86	1.96	1.96	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	150.56	17.43	3.25	1.88	1.88	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	160.63	13.13	3.28	0.36	0.18	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	156.11	16.06	2.45	1.10	1.72	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	147.35	17.86	3.09	1.75	1.75	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	246.02	15.80	2.83	0.24	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	171.03	19.05	3.17	1.39	1.39	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	153.40	14.50	3.51	1.17	0.70	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	177.91	13.06	3.73	0.41	0.00	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	178.96	20.57	6.86	1.99	0.88	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	157.29	16.92	2.30	0.84	0.84	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	195.01	14.94	3.36	0.94	0.00	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	129.42	13.96	2.90	1.19	1.87	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	151.34	17.16	4.82	1.74	1.16	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	210.97	13.93	4.30	0.86	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	132.37	15.50	2.74	1.37	1.51	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	153.99	18.39	2.96	0.82	0.66	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	194.12	15.34	1.87	0.51	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	188.65	22.19	3.99	1.33	2.52	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	126.61	13.86	1.60	0.80	1.87	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	158.73	16.32	4.70	0.28	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	155.00	16.67	2.62	0.71	1.90	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	183.60	19.55	3.43	1.41	2.42	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	166.69	16.01	5.84	1.60	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	127.52	18.87	4.19	1.05	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	122.40	12.09	0.91	1.51	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	207.20	19.21	5.02	0.49	0.12	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	158.07	21.11	7.13	0.87	1.16	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	115.60	16.43	2.43	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	196.21	15.97	4.52	0.30	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	121.24	18.77	3.39	1.13	1.13	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	145.58	20.37	3.89	0.00	1.80	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	147.83	17.59	4.37	0.71	0.12	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	97.97	14.94	5.34	0.21	1.28	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	118.39	15.63	1.80	1.20	0.60	1.80
Schwann Cells, donor1	11498-119F4	95.92	18.24	3.76	0.75	0.00	0.56
Schwann Cells, donor2	11578-120F3	95.27	10.21	0.00	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	107.79	21.47	1.97	0.44	1.97	0.88
Sebocyte, donor1	11220-116B5	246.50	48.75	7.67	2.74	4.93	1.10
Sebocyte, donor2	11301-117B5	123.62	28.49	6.43	4.14	4.14	1.84
Sebocyte, donor3	11378-118B1	98.73	20.20	6.39	1.24	2.06	1.24
Sertoli Cells, donor1	11255-116F4	205.42	28.16	8.28	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	112.97	14.12	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	102.93	17.95	2.90	1.76	1.41	0.62
Skeletal Muscle Cells, donor2	11358-117H8	32.53	2.89	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	66.05	10.03	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	93.78	13.82	3.46	1.57	0.00	0.63
Skeletal Muscle Cells, donor5	11455-119A6	81.46	14.27	2.53	1.78	0.15	0.59
Skeletal Muscle Cells, donor6	11459-119B1	95.42	14.77	4.00	2.15	0.31	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	155.11	21.67	3.65	3.02	1.26	2.14
Skeletal Muscle Satellite Cells, donor2	11321-117D7	113.87	15.70	2.28	1.28	1.57	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	94.25	16.77	3.57	2.18	1.09	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	118.29	18.96	2.95	1.60	1.60	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	32.57	4.34	2.90	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	54.21	7.02	2.06	1.51	0.00	0.41
Skin - palm, donor1	10286-104F7	204.14	18.80	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	67.90	13.98	4.04	1.01	0.86	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	139.86	13.90	9.00	1.64	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	86.85	14.41	6.23	1.30	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	98.28	20.85	6.67	2.92	0.83	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	64.70	14.35	2.95	1.55	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	97.05	15.65	6.34	0.85	1.48	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	101.41	24.36	4.35	2.02	2.32	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	144.73	15.43	3.09	2.47	0.00	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	64.03	9.34	3.11	0.22	0.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.78	10.58	1.76	2.35	0.59	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	89.50	32.71	3.31	1.77	4.86	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	68.52	13.39	5.91	0.39	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	65.67	17.00	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	217.16	35.03	5.00	1.00	6.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	69.60	16.10	3.86	0.93	0.40	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	129.00	16.18	4.21	3.55	0.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	43.91	7.43	3.20	1.66	0.00	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	84.33	14.65	4.23	1.63	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	92.44	18.61	4.13	1.48	2.07	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	89.55	20.22	3.27	2.99	2.28	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	104.44	19.85	3.74	2.11	0.81	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	147.35	19.48	3.35	3.35	1.22	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	89.15	14.90	3.03	0.76	1.77	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	59.60	15.74	2.38	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	118.86	19.91	4.72	1.62	1.03	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	110.20	21.95	3.01	1.51	1.29	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	99.71	15.43	3.46	1.99	1.47	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	68.37	16.71	3.87	1.55	0.31	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	45.27	9.70	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	63.36	13.75	5.68	2.39	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	125.98	23.56	4.10	3.41	1.37	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	164.99	23.87	2.91	1.10	1.02	1.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	74.27	23.95	8.76	1.11	1.01	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	124.02	21.39	7.05	1.37	1.37	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	74.27	10.26	2.42	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	184.92	29.14	5.03	5.83	1.59	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	153.93	19.31	5.19	2.80	0.13	1.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	129.48	21.29	3.76	4.01	1.63	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	123.79	22.83	3.30	2.54	2.54	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	86.24	18.24	4.67	0.90	1.51	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	54.76	10.50	2.25	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	149.90	156.36	2.58	9.05	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	80.46	18.14	3.26	0.47	0.93	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	79.77	19.19	3.03	1.51	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	47.01	14.73	6.58	1.57	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	89.09	15.63	2.06	1.18	1.18	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	131.21	20.83	4.83	1.67	1.75	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	103.71	20.56	3.27	0.93	2.80	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	73.97	19.14	3.60	1.01	0.43	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	75.21	13.77	3.57	1.27	1.27	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	54.15	8.65	1.69	0.38	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	158.75	24.73	6.01	3.21	1.54	1.68
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	117.05	17.34	4.19	2.09	0.92	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	68.57	9.05	0.48	1.43	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	72.91	15.17	2.94	1.96	0.73	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	132.35	19.22	6.19	4.20	0.44	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	99.77	11.70	3.80	1.17	0.88	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	111.95	21.96	4.28	0.58	1.36	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	93.88	16.93	4.76	1.32	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	202.34	29.76	8.93	2.98	2.23	3.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	124.33	21.20	7.19	2.16	1.44	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	87.16	12.49	7.38	2.84	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	142.19	20.48	5.91	1.58	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	116.82	15.49	5.08	0.76	1.52	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	89.45	11.58	0.80	1.20	1.60	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	83.18	16.72	2.51	0.00	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	123.76	19.71	6.42	2.75	1.38	0.46
Synoviocyte, donor1	11291-117A4	126.24	22.89	4.04	1.35	1.18	1.51
Synoviocyte, donor2	11368-117I9	177.85	33.02	6.37	2.01	2.85	1.84
Synoviocyte, donor3	11440-118H9	111.70	15.42	1.79	0.67	0.00	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	171.88	21.80	4.65	2.50	1.79	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	71.35	13.87	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	63.68	11.35	3.01	1.16	1.62	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	76.42	13.55	3.87	1.15	0.93	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	63.78	11.21	1.55	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	32.64	5.15	5.15	0.57	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	292.80	36.17	9.72	1.72	4.06	0.25
Urethra, donor2	10319-105A4	266.17	59.35	10.79	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	115.56	26.30	7.17	0.80	0.80	0.00
Urothelial Cells, donor2	11600-120H7	119.77	18.43	4.81	1.20	0.40	0.80
Urothelial Cells, donor3	11681-122H7	109.56	18.79	3.90	0.23	1.15	0.46
Urothelial cells, donor0	11216-116B1	188.79	22.29	2.90	2.01	1.78	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	1566.91	225.12	56.95	0.89	0.00	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	1505.38	215.87	41.46	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	836.48	130.06	17.80	2.05	15.06	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	717.94	134.64	22.04	3.10	5.85	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	712.92	147.58	29.05	0.58	5.81	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	1466.07	236.36	53.10	1.04	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	1379.44	187.23	44.05	0.92	0.00	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	711.15	116.85	21.91	0.91	8.22	0.00
Wilms' tumor cell line:G-401	10809-111A8	96.72	15.67	6.66	1.73	1.48	1.48
Wilms' tumor cell line:HFWT	10597-108E3	20.24	3.52	1.76	3.52	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	275.41	42.46	11.45	2.79	1.12	1.12
achilles tendon, donor2	10292-104G4	225.25	39.26	8.27	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	120.08	14.79	1.78	0.51	1.78	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	284.41	45.51	12.54	1.16	3.48	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	345.44	35.73	8.31	0.71	2.73	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	233.75	43.54	15.78	2.18	2.99	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	148.69	37.95	11.24	0.28	0.56	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	250.18	70.85	22.84	1.90	5.29	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	253.70	57.44	19.87	2.18	2.72	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	226.05	42.74	12.34	2.20	1.76	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	282.18	48.59	8.98	0.41	1.63	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	290.45	45.82	13.59	0.78	4.27	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	262.38	48.39	11.78	2.02	1.66	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	265.24	35.10	3.90	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	154.53	37.41	12.55	1.63	1.16	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	479.23	81.55	27.96	3.62	2.33	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	344.85	57.28	14.90	3.21	2.92	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	196.13	33.46	9.30	0.93	2.32	3.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	386.99	83.48	21.39	1.65	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	199.21	28.24	11.05	0.31	0.61	3.07
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	449.32	54.62	15.79	6.40	7.25	5.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	498.61	64.30	14.25	2.43	7.28	4.25
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	507.17	63.79	17.33	2.65	5.30	5.05
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	386.90	88.87	29.62	4.23	2.23	3.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	194.79	25.68	8.34	3.34	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	81.76	9.29	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	149.91	50.10	19.21	2.64	2.64	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	218.07	62.80	26.60	1.74	2.62	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	108.72	28.12	29.99	0.00	5.62	3.75
adenocarcinoma cell line:IM95m	10796-110I4	310.39	44.27	10.13	1.41	3.30	0.71
adipose tissue, adult, pool1	10010-101C1	234.39	37.54	7.91	0.31	1.09	0.31
adipose, donor1	10184-103D4	90.31	7.62	3.52	2.35	1.17	0.59
adipose, donor2	10185-103D5	51.10	3.65	1.22	0.81	0.41	2.03
adipose, donor3	10186-103D6	72.97	11.44	1.09	1.63	14.43	1.36
adipose, donor4	10187-103D7	65.87	7.80	0.00	0.00	19.07	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	186.23	14.68	3.79	3.47	2.68	0.32
adrenal gland, adult, pool1	10081-102A9	94.58	21.83	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	328.71	50.69	9.07	2.13	4.67	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	267.26	33.94	8.58	1.79	2.86	0.71
amniotic membrane cells, donor1	12235-129G3	157.43	12.75	3.25	0.70	1.39	0.46
amniotic membrane cells, donor2	12236-129G4	169.05	22.99	4.73	1.01	4.06	1.01
amniotic membrane cells, donor3	12237-129G5	237.15	12.08	4.12	1.18	0.59	0.88
amygdala - adult, donor10196	10167-103B5	387.76	46.25	14.23	5.93	1.19	0.00
amygdala, adult, donor10252	10151-102I7	371.06	34.88	8.72	2.64	5.68	1.01
amygdala, newborn, donor10223	10360-105E9	174.62	36.47	7.75	2.58	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	197.11	30.43	6.88	1.40	1.15	3.06
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	171.42	23.39	5.07	3.09	3.09	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	191.07	19.71	3.01	1.00	1.67	0.67
aorta, adult, pool1	10052-101G7	255.56	40.21	8.83	1.18	3.33	0.78
appendix, adult	10189-103D9	215.41	38.04	12.81	0.78	3.10	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	222.18	16.16	3.44	2.06	0.69	0.34
artery, adult	10190-103E1	148.10	16.30	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	257.86	51.57	12.60	1.88	2.03	1.16
b cell line:RPMI1788	10427-106D4	149.15	13.83	4.91	0.59	1.34	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	106.26	17.76	2.77	1.66	2.50	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	132.97	24.71	10.52	1.89	1.98	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	167.04	40.34	13.89	1.17	2.01	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	178.40	60.96	15.66	1.12	1.12	1.68
bladder, adult, pool1	10011-101C2	289.53	32.70	4.56	0.87	2.28	0.43
blood, adult, pool1	10053-101G8	469.50	101.87	11.07	2.21	13.29	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	122.46	18.84	5.99	0.00	0.86	0.00
bone marrow, adult	10192-103E3	218.64	35.77	10.12	1.35	0.67	0.67
brain, adult, donor1	10084-102B3	187.59	31.78	17.43	2.05	2.05	0.00
brain, adult, pool1	10012-101C3	397.55	50.33	14.48	2.45	3.12	0.56
brain, fetal, pool1	10085-102B4	90.83	18.70	13.36	0.00	0.00	5.34
breast carcinoma cell line:MCF7	10482-107A5	484.31	52.20	10.57	2.64	4.29	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	377.96	53.05	11.98	2.12	3.87	1.62
breast, adult, donor1	10080-102A8	146.47	23.99	3.79	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	232.10	35.44	3.30	1.65	3.18	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	223.26	20.72	4.64	1.24	1.55	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	275.11	34.07	6.45	7.60	0.92	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	97.56	13.31	3.87	0.73	0.97	0.97
carcinoid cell line:NCI-H1770	10703-109H1	91.21	7.99	2.82	2.35	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	164.84	21.22	6.45	1.42	1.09	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	205.03	33.91	10.77	4.12	0.63	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	217.20	20.50	7.19	2.13	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	627.47	72.53	19.57	2.30	5.76	0.00
caudate nucleus, adult, donor10252	10164-103B2	327.29	40.16	8.87	2.84	3.85	1.51
caudate nucleus, adult, donor10258	10379-105H1	239.94	42.79	12.99	2.29	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	212.42	34.43	10.25	2.56	0.37	2.20
cerebellum - adult, donor10196	10173-103C2	751.62	75.75	23.31	5.83	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	447.95	40.35	8.97	2.99	6.41	0.85
cerebellum, adult, pool1	10083-102B2	216.97	23.46	9.31	1.72	1.72	0.34
cerebellum, newborn, donor10223	10357-105E6	238.29	32.38	5.81	0.83	1.66	0.00
cerebral meninges, adult	10188-103D8	188.35	31.77	11.60	2.52	1.76	0.50
cerebrospinal fluid, donor2	10294-104G6	173.22	27.77	6.58	0.73	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	174.84	29.48	10.93	1.15	1.87	2.88
cervical cancer cell line:ME-180	10553-107I4	295.80	63.80	21.87	2.49	3.48	0.99
cervix, adult, pool1	10013-101C4	294.39	36.12	9.66	1.36	2.31	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	262.79	35.11	9.75	2.51	1.95	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	33.96	6.53	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	67.98	8.70	2.36	0.37	0.37	0.62
choriocarcinoma cell line:SCH	10785-110H2	105.35	11.71	3.20	1.72	1.23	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	24.67	4.03	1.42	0.95	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	116.82	11.97	2.28	0.00	1.14	0.00
chorionic membrane cells, donor2	12239-129G7	140.70	18.99	4.37	1.49	1.59	0.40
chorionic membrane cells, donor3	12240-129G8	153.31	23.08	6.04	0.00	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	195.90	23.23	9.09	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	184.41	42.65	15.94	1.54	3.27	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	183.94	52.37	15.42	1.06	3.80	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	189.52	16.18	4.11	3.60	1.28	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	220.59	21.53	7.01	6.29	0.48	4.11
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	233.54	25.86	7.33	5.90	1.63	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	181.97	20.02	3.83	4.71	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	253.85	107.38	34.92	2.35	4.95	3.13
clear cell carcinoma cell line:JHOC-5	10638-108I8	205.27	25.14	5.03	0.91	1.14	0.69
clear cell carcinoma cell line:TEN	10636-108I6	327.93	40.95	10.93	5.90	2.78	2.43
colon carcinoma cell line:CACO-2	10513-107D9	133.62	16.84	6.59	1.46	1.28	0.55
colon carcinoma cell line:COLO-320	10420-106C6	469.78	24.71	6.46	3.42	1.90	2.28
colon, adult, donor1	10082-102B1	171.36	33.32	9.52	1.19	4.76	0.00
colon, adult, pool1	10014-101C5	312.09	53.35	11.16	0.82	4.47	0.24
colon, fetal, donor1	10070-101I7	174.27	33.99	8.65	0.00	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	50.42	9.17	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	75.11	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	122.81	29.75	7.22	1.27	2.12	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	125.42	27.32	5.13	0.75	0.91	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	148.20	28.34	8.18	0.85	1.41	0.56
corpus callosum, adult, pool1	10042-101F6	863.71	80.49	14.70	5.53	6.41	1.00
cruciate ligament, donor2	10295-104G7	272.32	39.71	16.21	0.00	5.67	0.81
diaphragm, fetal, donor1	10069-101I6	83.47	11.24	6.42	1.61	1.61	0.80
diencephalon, adult	10193-103E4	330.46	36.24	6.72	2.40	1.44	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	264.05	62.91	15.84	0.46	3.21	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	224.64	49.24	17.69	2.05	1.03	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	56.57	11.80	5.30	3.85	0.48	0.72
ductus deferens, adult	10196-103E7	198.84	46.35	11.96	1.00	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	181.47	37.45	7.20	0.00	2.88	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	275.13	44.14	8.09	1.47	0.00	2.21
dura mater, adult, donor1	10041-101F5	563.16	90.85	20.65	2.81	5.95	1.98
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	83.06	12.88	6.44	2.22	0.67	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	178.97	24.36	7.02	5.45	0.72	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	115.31	13.57	2.47	3.08	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	220.07	26.64	4.24	3.03	0.61	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	142.33	16.05	3.09	0.62	1.23	0.62
embryonic pancreas cell line:2C6	10603-108E9	173.38	14.45	3.94	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	248.04	78.77	12.07	6.03	2.68	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	216.21	22.65	6.71	1.09	1.99	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	164.03	27.98	8.68	1.61	0.64	2.09
epidermoid carcinoma cell line:A431	10426-106D3	170.52	30.90	7.67	2.11	1.67	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	173.78	32.34	10.23	1.32	1.76	0.66
epididymis, adult	10197-103E8	261.64	38.30	9.21	1.88	2.30	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	182.20	18.98	5.85	2.31	1.95	2.31
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	86.12	18.48	3.15	1.97	0.39	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	302.33	23.85	7.08	2.10	4.85	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	250.09	23.52	5.12	1.28	4.43	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	286.12	27.00	7.28	2.13	4.93	0.67
esophagus, adult, pool1	10015-101C6	229.13	37.59	10.30	1.27	2.34	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	215.53	48.59	8.89	1.25	2.88	4.76
eye - muscle inferior rectus, donor1	10272-104E2	178.68	24.15	7.24	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	157.82	29.46	4.21	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	56.55	14.88	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	116.94	18.34	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	174.89	43.72	7.29	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	193.98	30.00	5.59	0.25	3.56	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	122.07	13.08	2.56	2.18	1.54	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	160.26	18.04	4.99	2.61	0.95	2.37
frontal lobe, adult, pool1	10040-101F4	417.61	58.73	18.48	4.22	3.38	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	331.48	66.05	18.32	2.40	5.40	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	268.82	41.33	11.80	2.10	2.38	3.11
gall bladder, adult	10198-103E9	197.97	44.42	9.90	1.69	2.66	0.24
gamma delta positive T cells, donor1	11937-126A2	629.73	79.45	12.35	1.07	5.37	0.00
gamma delta positive T cells, donor2	11938-126A3	580.41	88.89	19.05	0.00	6.72	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	172.56	21.33	6.34	1.27	2.11	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	208.12	41.97	7.74	1.16	2.90	0.39
gastric cancer cell line:AZ521	10549-107H9	206.58	30.17	8.20	2.95	0.98	2.62
gastric cancer cell line:GSS	10560-108A2	163.83	16.47	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	64.88	13.94	3.66	0.91	0.23	1.37
giant cell carcinoma cell line:LU65	10487-107B1	90.07	10.90	1.03	0.23	0.69	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	237.51	26.45	6.58	7.00	0.98	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	188.06	17.71	5.74	1.75	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	193.90	18.16	4.12	1.37	0.95	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	186.92	16.01	4.35	1.40	2.39	0.70
glioblastoma cell line:T98G	10485-107A8	136.31	16.67	4.97	1.32	1.55	1.21
glioma cell line:GI-1	10413-106B8	245.72	26.07	6.15	2.34	2.34	1.46
globus pallidus - adult, donor10196	10175-103C4	419.12	49.57	14.58	1.46	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	616.83	50.28	11.47	3.91	7.32	0.49
globus pallidus, adult, donor10258	10367-105F7	460.05	38.34	19.17	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	170.53	28.78	9.06	3.73	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	14.68	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	207.64	87.43	43.71	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	292.69	52.27	36.59	5.23	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	110.72	14.40	4.48	2.24	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	49.58	7.80	4.13	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	56.24	7.32	1.37	1.37	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	56.04	7.73	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	30.18	0.00	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	33.61	4.80	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	350.90	32.00	17.66	6.62	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	181.31	40.52	11.21	0.57	3.45	1.15
heart - mitral valve, adult	10205-103F7	181.47	27.80	5.38	1.20	1.49	0.30
heart - pulmonic valve, adult	10206-103F8	229.31	24.84	3.40	1.31	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	100.75	18.32	4.16	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	241.60	40.40	13.06	1.22	2.86	1.22
heart, adult, diseased, donor1	10051-101G6	291.27	29.81	6.39	1.28	0.85	0.00
heart, adult, pool1	10016-101C7	208.36	22.08	5.29	1.15	1.15	0.00
heart, fetal, pool1	10046-101G1	300.96	32.04	6.98	0.92	2.16	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	151.49	27.77	5.86	2.47	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	41.62	2.38	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	120.00	12.04	3.09	1.66	2.76	2.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	121.50	14.81	2.55	0.97	2.31	2.91
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	133.59	15.66	3.03	1.92	2.83	2.43
hepatoma cell line:Li-7	10484-107A7	273.03	52.61	9.56	2.11	2.45	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	96.68	9.75	2.11	0.60	1.51	0.20
hippocampus - adult, donor10196	10169-103B7	383.26	52.99	17.03	6.62	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	459.43	39.19	7.55	3.47	5.31	0.61
hippocampus, adult, donor10258	10374-105G5	393.38	27.89	9.96	1.99	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	89.88	20.80	7.05	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	39.67	4.88	4.27	1.83	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	28.86	2.95	0.98	0.98	0.39	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	28.44	3.81	0.76	0.00	0.00	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	52.44	3.38	1.13	0.56	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	50.87	3.61	2.07	0.52	0.52	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	74.40	6.83	3.42	0.00	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	68.61	10.51	2.92	0.58	0.58	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	71.74	9.05	3.23	2.15	0.43	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	71.32	10.84	6.26	1.25	1.25	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	142.31	16.10	5.21	1.42	1.89	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	114.75	14.63	3.70	1.45	0.48	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	106.38	18.18	5.39	0.00	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.32	3.91	0.94	0.31	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	28.00	2.95	0.49	0.00	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	52.37	5.24	0.87	0.00	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	59.37	6.68	1.34	1.15	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	50.15	4.80	0.44	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	66.97	6.00	1.50	1.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	96.64	9.80	3.58	1.70	0.00	3.96
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	104.13	8.64	2.73	1.82	0.00	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	94.28	8.46	4.07	1.88	0.63	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	120.19	14.04	4.57	1.31	0.98	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	129.19	16.26	4.35	1.74	0.87	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	101.04	9.27	5.08	1.49	1.49	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.76	5.17	1.48	0.18	0.18	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	38.23	3.71	1.71	0.00	0.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.49	4.08	2.04	0.41	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	49.29	5.28	1.06	1.41	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	51.31	6.97	0.95	1.58	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	44.18	6.05	0.91	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	95.15	9.83	1.55	3.10	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	110.25	9.30	1.99	3.32	0.00	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	62.85	7.70	3.33	0.77	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	140.35	16.11	5.11	0.51	1.28	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	122.67	17.42	6.82	2.27	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	115.94	17.14	4.37	2.02	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.26	6.04	0.72	0.97	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	46.35	5.79	2.23	1.78	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	27.81	3.90	0.49	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	63.87	4.28	1.53	1.22	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	383.88	6.51	6.51	3.25	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	84.39	11.25	2.32	2.32	0.66	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	116.03	11.49	2.74	2.19	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	107.84	11.58	2.90	1.45	0.72	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	101.78	11.74	3.91	2.14	0.00	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	161.11	17.90	4.77	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	196.91	27.49	6.77	2.71	1.35	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	128.23	14.82	4.85	1.08	0.81	1.35
immature langerhans cells, donor1	11904-125F5	749.93	117.93	38.50	0.97	4.60	1.70
immature langerhans cells, donor2	11905-125F6	457.85	94.26	28.52	2.38	7.92	3.17
insula, adult, pool1	10039-101F3	386.67	57.54	19.78	2.93	4.26	1.99
keratoacanthoma cell line:HKA-1	10791-110H8	178.51	26.99	13.01	0.33	4.23	2.60
kidney, adult, pool1	10017-101C8	473.30	81.60	19.42	3.50	6.11	1.20
kidney, fetal, pool1	10045-101F9	442.66	66.56	15.70	1.84	2.55	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	116.03	25.71	8.81	2.70	0.57	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	165.06	12.99	2.07	2.07	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	240.75	19.08	5.50	4.59	0.73	0.73
left atrium, adult, donor1	10079-102A7	228.29	34.33	4.90	3.27	2.18	0.54
left ventricle, adult, donor1	10078-102A6	165.35	16.18	4.05	0.51	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	111.36	11.49	4.65	2.74	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	71.85	12.21	4.31	1.80	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	78.26	13.59	4.89	1.63	0.00	0.00
leiomyoma cell line:15425	10571-108B4	87.66	13.84	1.94	2.19	0.97	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	107.94	6.35	12.70	0.00	0.00	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	178.79	24.05	7.32	1.05	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	161.62	53.48	19.13	3.54	5.31	2.24
liposarcoma cell line:KMLS-1	10782-110G8	103.25	15.00	2.34	2.03	1.25	0.94
liposarcoma cell line:SW 872	10726-110A6	180.57	16.20	4.02	1.95	1.58	1.22
liver, adult, pool1	10018-101C9	335.79	41.16	10.37	1.46	2.43	0.49
liver, fetal, pool1	10086-102B5	97.83	15.99	4.70	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	254.76	32.37	7.00	3.35	1.90	1.17
locus coeruleus, adult, donor10252	10165-103B3	437.39	43.00	10.70	3.69	4.24	1.29
locus coeruleus, adult, donor10258	10375-105G6	229.66	36.40	7.34	2.26	1.41	0.85
locus coeruleus, newborn, donor10223	10362-105F2	447.54	60.99	22.71	6.73	4.63	0.42
lung adenocarcinoma cell line:A549	10499-107C4	174.65	22.56	4.57	0.83	2.21	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	221.99	39.30	7.58	0.69	1.38	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	230.68	33.09	12.65	2.11	1.71	1.71
lung, adult, pool1	10019-101D1	341.27	61.90	10.04	1.30	6.02	0.71
lung, fetal, donor1	10068-101I5	822.83	119.59	35.68	3.71	0.29	0.86
lung, right lower lobe, adult, donor1	10075-102A3	293.26	55.44	12.83	1.37	3.67	0.00
lymph node, adult, donor1	10077-102A5	310.53	51.12	24.14	0.95	4.73	0.95
lymphangiectasia cell line:DS-1	10727-110A7	224.88	40.99	6.36	1.97	5.26	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	191.37	27.77	10.56	0.91	1.81	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	395.86	58.62	16.99	2.55	3.40	0.00
mature adipocyte, donor1	12231-129F8	74.59	7.10	2.22	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	108.12	10.58	1.87	0.42	1.04	0.00
mature adipocyte, donor3	12233-129G1	147.93	13.75	4.74	0.71	0.47	0.47
mature adipocyte, donor4	12234-129G2	185.31	11.84	3.95	0.26	1.32	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	499.87	62.90	19.30	5.72	2.38	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	401.58	62.04	28.20	2.26	4.51	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	349.42	39.72	8.46	4.97	5.89	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	217.93	28.91	10.48	1.59	1.59	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	261.01	46.06	13.22	3.84	1.71	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	314.89	52.14	17.04	4.56	1.69	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	412.99	41.81	11.04	2.33	5.52	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	261.97	17.34	7.71	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	746.39	57.41	57.41	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	114.86	30.51	7.90	1.79	0.36	2.87
medulla oblongata - adult, donor10196	10174-103C3	464.67	36.99	18.82	1.95	2.60	0.00
medulla oblongata, adult, donor10252	10155-103A2	498.16	44.12	9.75	2.94	4.95	0.77
medulla oblongata, adult, pool1	10038-101F2	571.47	72.97	16.49	5.55	4.98	1.14
medulla oblongata, newborn, donor10223	10361-105F1	241.64	31.25	7.64	1.39	1.39	1.04
medulloblastoma cell line:D283 Med	10838-111E1	183.99	17.71	3.54	2.66	0.66	0.22
medulloblastoma cell line:ONS-76	10759-110E3	134.38	15.16	4.16	3.18	2.69	1.83
melanoma cell line:COLO 679	10514-107E1	109.82	27.46	10.92	1.72	1.58	0.57
melanoma cell line:G-361	10465-106H6	157.45	30.40	8.69	2.17	0.81	1.36
meningioma cell line:HKBMM	10691-109F7	95.70	13.21	3.62	0.72	1.27	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	234.39	27.32	4.41	2.64	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	180.94	31.11	3.89	3.37	0.78	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	165.10	19.49	4.30	3.38	0.46	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	107.43	12.00	4.54	1.64	0.00	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	135.00	16.15	3.31	0.83	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	98.05	14.61	3.51	1.83	0.28	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	117.66	17.14	4.43	1.35	0.00	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	156.17	24.29	9.02	4.16	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	111.22	15.96	4.29	1.89	0.17	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	115.48	14.38	4.95	0.81	0.58	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	152.93	23.34	5.44	1.33	0.66	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	141.79	20.93	5.54	2.70	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	154.78	18.92	5.12	3.84	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	101.44	18.77	3.62	2.96	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	138.65	21.17	3.74	2.21	0.28	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	107.52	15.36	3.84	2.44	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	106.78	13.88	2.65	1.22	0.61	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	96.33	19.41	4.67	1.80	0.36	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	142.24	15.21	3.52	1.14	0.31	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	73.87	16.42	5.47	1.14	0.91	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	187.12	26.01	7.55	0.42	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	130.01	17.48	6.13	1.94	0.60	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	146.79	21.36	5.78	2.45	0.79	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	132.91	13.99	2.95	2.21	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	80.41	16.31	6.30	1.72	0.29	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	153.25	17.68	3.79	2.95	0.42	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	98.18	11.87	2.28	0.46	1.83	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	108.20	15.60	3.58	2.05	1.53	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	123.29	15.18	3.93	0.79	1.83	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	106.91	17.25	3.39	0.62	1.85	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	122.38	15.77	2.82	1.65	2.12	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	118.80	12.86	1.69	1.35	2.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	115.14	16.11	2.75	1.57	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	109.82	14.36	1.85	1.85	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	130.08	17.88	2.31	1.15	2.31	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	111.55	15.62	3.35	1.12	0.45	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	115.61	11.30	3.12	1.20	1.68	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	104.87	16.13	4.40	2.20	1.47	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	115.80	12.08	1.34	2.01	2.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	130.59	11.87	3.68	1.23	0.41	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	107.39	15.89	3.01	0.86	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	79.30	19.14	5.47	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	15.49	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	90.94	13.32	1.30	1.62	0.97	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	101.85	14.55	4.36	0.00	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	92.76	11.73	3.73	0.00	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	85.87	12.27	4.91	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	84.74	12.44	3.89	0.78	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	86.05	14.69	4.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	75.50	14.90	1.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	19.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	80.05	11.27	2.37	1.19	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	88.95	13.40	6.09	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	91.84	6.33	3.17	1.90	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	71.40	14.14	4.48	1.03	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	66.63	12.90	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	99.79	11.98	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	96.43	10.33	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	64.38	12.63	2.04	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	76.27	16.68	3.18	1.59	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	93.73	17.10	1.18	0.00	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	88.52	14.03	3.74	1.25	0.62	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	92.23	20.05	2.67	0.00	5.35	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	76.87	20.11	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	61.63	25.68	2.57	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	106.01	14.46	1.38	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	102.92	16.82	1.48	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	57.20	11.22	1.12	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	68.06	11.45	1.27	0.64	0.64	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	64.48	9.67	3.63	0.00	2.42	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	58.88	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	67.15	13.94	2.53	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	66.76	7.89	0.00	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	9.04	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	59.30	6.59	1.65	0.82	1.65	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	81.95	13.29	2.78	1.19	0.20	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	74.63	11.03	3.24	1.30	0.00	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	77.42	12.22	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	95.17	12.38	2.32	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	316.80	25.04	4.49	2.60	0.71	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	176.30	25.25	6.72	1.62	1.62	3.94
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	170.94	17.09	17.09	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	105.11	21.78	7.19	1.34	1.34	0.51
mesothelioma cell line:Mero-25	10850-111F4	143.43	20.65	9.53	1.13	0.91	3.18
mesothelioma cell line:Mero-41	10851-111F5	305.59	28.85	7.33	4.16	1.47	0.24
mesothelioma cell line:Mero-48a	10852-111F6	161.64	22.59	8.19	1.99	0.89	0.89
mesothelioma cell line:Mero-82	10853-111F7	117.74	22.34	8.15	0.79	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	163.75	18.89	7.49	2.38	1.19	0.17
mesothelioma cell line:Mero-84	10855-111F9	286.90	40.70	8.09	3.29	2.02	0.76
mesothelioma cell line:Mero-95	10856-111G1	240.58	25.67	7.25	1.45	2.07	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	137.82	16.40	6.96	2.15	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	251.04	32.22	9.59	4.52	0.90	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	246.33	29.38	5.64	2.22	2.05	0.34
mesothelioma cell line:NCI-H28	10845-111E8	242.00	18.07	5.85	1.78	1.27	2.04
mesothelioma cell line:No36	10857-111G2	229.97	32.62	9.46	0.65	0.65	1.63
mesothelioma cell line:ONE58	10858-111G3	296.69	40.64	14.90	3.52	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	493.62	71.20	15.55	0.38	4.61	1.15
migratory langerhans cells, donor2	11902-125F3	273.29	43.84	7.20	0.73	1.83	1.22
migratory langerhans cells, donor3	11903-125F4	348.01	65.33	12.74	1.26	2.15	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	147.57	27.42	5.88	3.26	0.33	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	103.42	33.27	11.02	1.06	1.27	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	96.98	18.66	3.69	0.92	1.84	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	156.42	19.22	3.23	0.38	2.09	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	177.03	33.82	6.47	0.55	2.77	1.66
myeloma cell line:PCM6	10474-106I6	85.19	14.43	1.78	0.00	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	102.98	10.15	3.55	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	248.51	42.95	8.43	2.55	4.51	2.35
nasal epithelial cells, donor1, tech_rep1	12226-129F3	113.76	20.72	5.46	1.89	1.00	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	124.65	19.56	4.78	2.94	1.40	0.96
nasal epithelial cells, donor2	12227-129F4	120.89	20.42	3.31	0.00	8.83	0.55
neuroblastoma cell line:CHP-134	10508-107D4	179.22	14.03	3.68	1.15	0.46	0.69
neuroblastoma cell line:NB-1	10539-107G8	262.67	26.75	4.86	3.55	2.81	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	217.64	21.09	6.12	2.32	1.48	1.27
neuroblastoma cell line:NH-12	10555-107I6	235.73	16.59	5.78	1.12	1.68	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	247.19	22.30	3.56	1.42	2.37	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	256.73	37.69	11.25	2.22	3.17	2.85
neuroectodermal tumor cell line:TASK1	10774-110F9	112.10	17.71	5.43	0.20	1.21	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	93.46	7.63	3.18	1.91	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	92.36	13.31	0.80	0.53	2.40	0.27
neutrophil PMN, donor1	12133-128D9	89.25	29.75	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	491.38	119.53	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	483.00	94.71	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	447.83	79.99	13.02	2.20	3.38	2.54
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	205.73	39.22	4.80	0.00	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	87.20	11.54	3.85	1.28	1.92	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	161.07	19.71	4.99	2.89	1.58	1.31
nucleus accumbens, adult, pool1	10037-101F1	404.39	56.43	15.94	3.84	4.12	1.22
occipital cortex - adult, donor10196	10172-103C1	597.51	86.54	26.78	2.06	10.30	6.18
occipital cortex, adult, donor10252	10163-103B1	454.61	44.28	8.32	4.29	6.17	0.54
occipital cortex, newborn, donor10223	10355-105E4	127.38	32.39	13.83	0.36	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	284.44	51.17	17.58	4.46	1.31	1.57
occipital lobe, fetal, donor1	10073-102A1	165.63	32.61	11.16	1.29	3.00	2.15
occipital pole, adult, pool1	10036-101E9	406.59	58.58	18.69	3.47	4.42	0.63
olfactory region, adult	10195-103E6	320.01	39.36	10.51	2.29	3.06	0.76
optic nerve, donor1	10277-104E7	450.24	42.02	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	227.47	31.67	8.20	1.94	2.51	5.35
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	190.83	16.21	3.02	2.06	0.82	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	304.95	50.97	15.24	4.06	2.03	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	169.34	36.15	12.36	3.12	3.12	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	130.52	16.76	4.12	2.94	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	81.29	21.49	2.80	0.93	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	154.38	26.30	6.15	0.85	0.85	1.06
ovary, adult, pool1	10020-101D2	252.10	24.81	5.33	0.79	2.18	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	142.62	20.35	3.85	2.93	2.20	0.37
pancreas, adult, donor1	10049-101G4	176.84	30.10	6.58	1.88	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	53.95	7.55	2.24	0.28	1.12	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	176.32	26.92	6.13	1.70	1.70	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	264.77	46.86	8.28	2.65	2.32	1.49
paracentral gyrus, adult, pool1	10035-101E8	380.00	57.57	16.75	4.48	3.84	1.46
parietal cortex, adult, donor10258	10373-105G4	301.68	44.77	14.68	2.20	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	343.28	47.02	12.23	4.70	3.76	0.94
parietal lobe, adult, donor10252	10157-103A4	359.15	37.91	13.68	2.85	3.99	0.29
parietal lobe, adult, pool1	10034-101E7	397.16	53.93	16.57	5.20	4.23	1.50
parietal lobe, fetal, donor1	10072-101I9	261.86	28.13	10.67	0.97	0.97	2.91
parietal lobe, newborn, donor10223	10356-105E5	152.53	40.00	12.71	1.50	1.12	1.50
parotid gland, adult	10199-103F1	193.63	44.40	11.10	0.62	0.62	0.00
penis, adult	10200-103F2	201.42	23.63	6.98	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	302.70	26.77	8.55	1.30	0.56	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	253.07	61.63	24.19	2.48	3.21	0.58
pineal gland - adult, donor10196	10179-103C8	270.27	27.74	6.45	3.87	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	386.71	32.57	10.07	2.37	3.55	0.59
pineal gland, adult, donor10258	10377-105G8	232.02	28.22	6.27	4.39	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	237.77	26.31	7.08	5.06	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	296.55	26.58	7.30	1.04	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	139.60	13.62	5.11	3.40	1.70	0.85
placenta, adult, pool1	10021-101D3	179.53	31.28	11.18	0.54	2.04	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	241.15	25.16	5.30	1.85	1.32	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	238.44	18.99	4.05	2.65	2.33	0.78
pons, adult, pool1	10033-101E6	370.61	49.14	17.39	4.91	2.41	1.72
postcentral gyrus, adult, pool1	10032-101E5	388.19	61.46	17.87	3.66	4.01	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	6.27	6.27	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	319.47	71.60	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	445.96	58.68	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	333.86	41.80	9.91	4.95	2.91	2.91
prostate cancer cell line:PC-3	10439-106E7	72.42	14.88	3.81	0.36	0.73	0.73
prostate, adult, pool1	10022-101D4	265.09	37.82	8.98	0.91	2.81	0.27
putamen, adult, donor10196	10176-103C5	340.17	40.84	12.28	4.01	5.19	1.18
putamen, adult, donor10252	10152-102I8	221.56	21.57	1.96	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	197.80	12.02	3.28	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	273.02	32.13	8.94	1.69	0.48	1.45
putamen, newborn, donor10223	10365-105F5	502.27	70.47	26.24	6.00	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	183.87	28.80	9.31	1.16	2.04	0.58
rectum, fetal, donor1	10067-101I4	100.15	23.65	4.17	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	231.93	32.44	5.51	1.70	1.27	2.76
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	195.51	14.50	4.97	1.66	1.24	0.41
retina, adult, pool1	10030-101E3	450.98	49.40	9.34	2.78	4.08	1.09
retinoblastoma cell line:Y79	10475-106I7	136.14	7.53	0.78	0.78	1.04	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	143.36	19.79	5.41	2.83	1.84	2.09
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	113.32	16.59	1.97	2.25	1.41	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	114.44	19.70	6.06	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	125.92	17.16	2.43	0.65	0.49	0.32
salivary acinar cells, donor2	11772-123I8	151.18	18.73	1.93	1.79	0.83	1.10
salivary acinar cells, donor3	11773-123I9	86.73	18.54	2.65	0.66	0.66	1.32
salivary gland, adult, pool1	10093-102C3	296.27	65.20	25.74	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	274.52	50.67	11.80	3.88	1.60	2.36
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	235.57	50.43	10.46	3.41	3.88	2.47
seminal vesicle, adult	10201-103F3	282.00	58.73	12.70	0.53	2.12	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	221.79	53.69	17.49	2.19	1.94	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	353.29	34.47	13.08	3.02	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	290.02	33.12	4.01	2.01	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	482.08	53.19	15.04	5.64	1.75	3.36
signet ring carcinoma cell line:Kato III	10436-106E4	350.93	71.40	17.02	3.87	2.43	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	332.24	67.09	20.64	2.19	2.58	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	152.51	12.77	3.55	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	178.47	20.39	4.32	0.72	1.08	0.12
skeletal muscle, fetal, donor1	10066-101I3	67.34	4.02	3.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	135.70	33.93	6.79	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	223.45	26.51	11.36	1.89	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	251.14	30.68	7.34	3.00	1.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	147.20	26.16	8.83	2.21	2.21	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	303.58	16.38	3.85	3.28	1.93	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	229.60	41.70	18.79	3.30	2.64	2.97
small cell lung carcinoma cell line:NCI-H82	10842-111E5	254.63	10.13	1.77	3.70	0.32	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	189.81	19.61	7.19	1.53	0.87	1.96
small intestine, adult, pool1	10024-101D6	508.47	91.97	17.56	1.55	8.36	0.84
small intestine, fetal, donor1	10064-101I1	309.09	62.65	12.04	2.21	5.65	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	114.89	22.57	2.56	0.00	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	226.67	20.16	4.14	1.29	1.29	0.26
somatostatinoma cell line:QGP-1	10781-110G7	122.75	27.34	4.29	0.80	3.22	0.54
spinal cord - adult, donor10196	10181-103D1	445.05	65.38	16.75	5.28	3.21	0.92
spinal cord, adult, donor10252	10159-103A6	718.36	61.51	12.62	3.55	4.73	0.79
spinal cord, adult, donor10258	10369-105F9	881.35	60.88	15.22	4.15	1.38	1.38
spinal cord, fetal, donor1	10056-101H2	275.65	33.54	6.71	3.05	3.05	0.61
spinal cord, newborn, donor10223	10359-105E8	495.49	64.75	13.78	4.13	5.05	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	89.46	12.40	2.09	1.19	1.79	0.60
spleen, adult, pool1	10025-101D7	391.31	73.79	8.59	1.32	6.83	1.10
spleen, fetal, pool1	10044-101F8	349.44	70.95	16.53	1.35	4.61	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	89.54	10.04	2.59	0.72	0.83	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	304.56	89.24	19.56	2.85	3.99	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	278.51	52.42	22.71	4.19	2.45	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	150.90	33.62	10.95	1.95	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	311.90	79.80	23.64	2.14	3.71	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	248.23	33.46	4.24	2.12	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	187.84	23.27	5.92	1.69	1.27	0.85
stomach, fetal, donor1	10062-101H8	165.54	30.97	5.34	1.07	2.14	0.00
submaxillary gland, adult	10202-103F4	160.08	41.02	11.96	0.57	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	542.74	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	605.88	49.23	11.42	2.91	6.85	0.42
substantia nigra, adult, donor10258	10371-105G2	420.01	41.90	15.52	3.62	0.00	2.59
substantia nigra, newborn, donor10223	10358-105E7	257.90	50.17	12.72	0.71	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	231.10	47.46	15.13	2.98	2.52	3.90
temporal lobe, adult, pool1	10031-101E4	382.15	51.46	16.70	3.05	3.48	1.70
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	198.01	29.92	8.55	1.42	2.85	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	165.71	20.66	7.47	1.32	0.44	0.88
tenocyte, donor1	11763-123H8	167.92	18.85	3.14	1.05	2.79	0.35
tenocyte, donor2	11765-123I1	165.19	17.55	1.14	0.76	2.67	1.91
tenocyte, donor3	11768-123I4	143.82	16.31	2.22	0.74	1.48	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	33.48	6.63	2.04	0.85	0.34	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	48.71	6.17	2.16	0.31	0.62	0.15
teratocarcinoma cell line:PA-1	10807-111A6	27.43	2.94	0.62	1.39	0.15	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	81.75	17.14	7.49	2.67	0.63	1.52
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	130.47	17.77	4.92	1.13	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	118.66	21.59	12.11	1.53	0.55	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	39.41	5.21	1.63	0.00	0.33	1.30
testis, adult, pool1	10026-101D8	262.53	33.29	9.66	3.76	3.22	2.15
testis, adult, pool2	10096-102C6	227.80	32.03	14.43	4.51	0.90	3.61
thalamus - adult, donor10196	10168-103B6	633.69	64.03	30.91	8.83	5.52	3.31
thalamus, adult, donor10252	10154-103A1	540.27	47.04	9.06	2.97	6.41	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	634.32	13.86	9.24	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	193.02	26.84	10.21	0.99	1.48	0.16
thalamus, newborn, donor10223	10366-105F6	212.29	35.67	12.66	2.30	0.58	1.73
throat, adult	10209-103G2	171.27	24.97	10.74	1.00	0.50	0.00
throat, fetal, donor1	10061-101H7	225.48	31.69	7.31	2.13	4.27	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	159.78	29.01	8.74	2.58	0.79	1.39
thymus, adult, pool1	10027-101D9	471.53	49.01	9.05	1.99	6.56	0.50
thymus, fetal, pool1	10043-101F7	452.50	48.84	10.49	1.87	6.03	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	150.11	19.01	4.65	1.86	0.40	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	163.02	13.69	2.93	1.82	1.82	0.70
thyroid, adult, pool1	10028-101E1	491.11	47.50	11.01	2.89	4.95	0.37
thyroid, fetal, donor1	10060-101H6	420.28	45.09	11.60	3.16	3.95	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	144.74	40.04	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	171.41	29.77	7.68	1.63	0.93	0.70
tongue, fetal, donor1	10059-101H5	112.71	14.19	9.06	0.39	1.58	0.79
tonsil, adult, pool1	10047-101G2	440.77	73.13	19.03	1.40	6.51	0.70
trachea, adult, pool1	10029-101E2	268.87	59.22	15.71	1.15	3.19	0.57
trachea, fetal, donor1	10058-101H4	143.88	34.24	12.31	0.77	3.46	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	117.27	17.01	4.61	2.48	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	92.00	19.96	4.15	0.71	0.71	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	207.14	29.77	10.65	2.66	3.13	1.57
tridermal teratoma cell line:HGRT	10694-109G1	41.86	3.81	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	294.50	52.48	12.27	3.13	3.81	0.34
umbilical cord, fetal, donor1	10057-101H3	169.01	25.04	8.35	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	424.18	39.07	11.77	1.02	0.68	0.51
uterus, fetal, donor1	10055-101H1	137.71	23.55	3.07	2.05	2.05	0.00
vagina, adult	10204-103F6	136.99	18.09	1.94	0.65	0.00	0.65
vein, adult	10191-103E2	231.91	40.55	9.64	0.44	1.97	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	97.20	12.55	2.40	0.27	1.07	0.27

Property "Nearest transcripts" (as page type) with input value "ENST00000549555.5:37 AK303828:37 ENST00000439799.6:39 ENST00000412716.8:39 ENST00000425012.6:39 NM_001136268.2:39 NM_001136267.2:39 NM_001136264.2:39 NM_001136266.2:39 NM_014764.4:39 NM_001136269.2:39 AK290119:39 AY430097:39 BX647278:39 AK293330:39 ENST00000551919.5:40 ENST00000549041.1:50 D31767:52 BC002334:55 BC007900:56 ENST00000449723.7:-59 ENST00000549732.6:67 AK095963:78 LF337998:81 MA573575:81 ENST00000604900.5:99 LF210452:-110 MA446029:-110 ENST00000436900.2:116 ENST00000551534.5:118 AB385271:119 CU677910:120 HQ447212:120 KJ892852:120 ENST00000552459.2:121 AK125855:121 ENST00000549497.5:127" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.